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Q U I L L  O N  S C A L P E L  mis section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
ACALCULOUS CHOLECYSTITIS
Acute and chronic acalculous chole­
cystitis are both recognized, if incompletely 
understood. In the acute form the signs and 
symptoms do not differ from those noted 
in patients with acute cholecystitis with 
stones. However, in acute acalculous chole­
cystitis there is usually no history of symp­
toms referable to the biliary tracts, many 
attacks occur after operation or trauma 
(especially in elderly patients), gangrene of 
the gallbladder is commoner, Escherichia 
coli is the commonest infecting organism 
and air may appear in the gallbladder. The 
pathogenesis, in the view of Howard and 
Delaney,1 is, in many cases, believed to be 
decreased gallbladder perfusion caused by 
arteriosclerosis possibly combined with a 
decreased cardiac output.
The quite unrelated problem of chronic 
acalculous cholecystitis is comprehensively 
reviewed by Cohen and Freeman in this 
issue of the Journal (page 571). Chole­
cystectomy on the basis of symptoms alone, 
despite a normal cholecystogram, gives a 
poor result in one-third to one-half of pa­
tients. For diagnosis, four tests in addition 
to routine cholecystography have been sug­
gested, and these are being evaluated in 
many centres to detect the patients who 
might be relieved of their symptoms by 
cholecystectomy. These test procedures are 
the following:
1. Cholecystokinin (CCK) cholecysto­
graphy to determine whether symptoms are 
reproduced during cholecystography.
2. CCK cholecystography and examina­
tion for radiographic abnormalities after 
injection of CCK.
3. Detection of cholesterol crystals from 
gallbladder bile obtained by duodenal 
drainage after provocation of gallbladder 
emptying.
4. Analysis of biliary lipids obtained 
from duodenal aspiration for detection of 
lithogenic bile.
Although the use of these tests is logical 
and recommended, the results have not 
been uniform. Differences in results may be 
attributable to the differences in techniques 
used by the several authors who have re­
ported their findings.
Cohen and Freeman have themselves 
shown that biliary lipid analysis is not 
helpful in this setting. Injection of CCK 
appears to provoke epigastric and right 
upper quadrant abdominal pain more fre­
quently in patients who benefit from chole­
cystectomy according to most, but not all, 
authors. There is still argument about how 
quickly CCK should be injected intra­
venously and what constitutes a positive 
radiographic finding. Failure to decrease 
volume by more than 50% within 15 
minutes, rapid contraction of the gallblad­
der by 80% within 5 minutes or “spasm” 
of the gallbladder or of the cystic duct have 
all been considered abnormal. However, 
Dunn and colleagues2 showed that when 
radiologists examined cholecystograms with­
out prior knowledge of the patients’ symp­
tomatic responses to CCK no significant 
difference between the symptomatic pa­
tients and controls was apparent.2 Further­
more, these authors found that CCK chole­
cystography was of no value in predicting 
which patients with symptoms suggestive of 
gallbladder disease could be benefited by 
cholecystectomy.2
Everyone caring for such patients is 
interested in pursuing their investigation to 
a diagnosis. Several controls are now in­
dicated. The amount of and the injection 
rate of CCK should be standardized; 75 
units in 3 minutes appears reasonable.
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Duodenal drainage appears to be a use­
ful addition to CCK cholecystography in 
that crystals of cholesterol or calcium bili­
rubinate can be identified in patients in 
whom radiographs are normal.
The report of Dunn and colleagues2 sug­
gests the need for a randomized study of 
patients whose condition meets the criteria 
for “chronic acalculous disease of the gall­
bladder” ; half of the patients would be 
operated on and the others would be ob­
served. During the follow-up period evi­
dence of symptomatic improvement would 
be sought, as well as possible spontaneous 
changes in the CCK cholecystogram and 
the nature of the contents of the duodenal 
drainage in the patients not undergoing 
cholecystectomy.
The review of Cohen and Freeman will 
be helpful to those interested in identifying 
the patients who could logically be included 
in such a study. It is probable that most 
patients with acalculous cholecystitis have
symptoms during periods when stones are 
formed and passed and are free of symp­
toms at other times. A personal clinical 
impression is that dietary control of this 
type of cholecystitis is better than for that 
of cholecystitis with demonstrated stones. 
This may be explicable on the basis of pre­
vention of further stone formation in those 
who form and pass stones and are symp­
tomatic only at those times.
L. D. MacL e a n , MD, FRCS[C]
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S E L F - A S S E S S M E N T
SESAP II QUESTION
404. Indications for coronary artery bypass grafting include
(1) disabling angina pectoris which is not relieved by medical therapy
(2) lesions demonstrated by arteriography that suggest a threat to life because 
of their location or extensiveness
(3) coronary artery stenosis associated with surgically correctable valvular 
heart disease or ventricular aneurysm
(4) severe ventricular dysfunction (ejection fraction of 35 per cent) associated 
with coronary artery disease
For this question one or more of the answers given above is correct. Your answer 
should be:
A if only 1, 2 and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E if all are correct.
For the critique of Item 404 see page 588 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II 
Syllabus: Surgical Education and Self-assessment Program No. 2.)
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ROLE OF SURGERY IN THE TREATMENT OF PULMONARY 
TUBERCULOSIS*
P. B. DAS, MS, FRCSrCl, FACS, FICS, FCCPt and 
J. G. DAVID, MDt
Summary: The records of 9939 patients hospital­
ized for tuberculosis between 1963 and 1972 
inclusive were reviewed with respect to pa­
tients who were treated surgically. During this 
period there was a steady decline in the number 
of patients thus treated; the success of anti­
microbial drug therapy has altered the fre­
quency of various surgical procedures, and 
pulmonary resection is now the procedure of 
choice, with a growing reluctance to perform 
segmental resection. Morbidity and complica­
tions among the patients in this series have 
been within acceptable limits. The problem 
of residual space has been minimal. Broncho­
pleural fistula with empyema (incidence, 3.1%) 
has been the most serious complication, ac­
counting for the largest proportion of deaths. 
The mortality of 2.8% is comparable to that 
reported in the literature. Though mild to mod­
erate respiratory insufficiency developed in 
some patients, none was seriously incapaci­
tated. The majority of surviving patients have 
remained well, with their disease under control. 
In a number of patients reactivation of the dis­
ease occurred, probably because of conserva­
tive resection and discontinuance of drug ther­
apy due to misunderstanding between patient 
and physician.
Resume: Les auteurs ont passe en revue les 
dossiers de 9939 malades hospitalises pour tu- 
berculose de 1963 a 1972 inclusivement, concer- 
nant les malades qui ont ete operes. Les succes 
qu'ont remporte les medicaments antitubercu- 
leux ont evidemment reduit la frequence des 
diverses operations et la pneumectomie est 
aujourd’hui ['alternative. On repugne de plus en 
plus a pratiquer des resections segmentaires. 
La morbidity et les complications parmi les ma-
*From the department of thoracic® and cardio­
vascular surgery, and chest medicine, Wanless 
Chest Hospital and Miraj Medical Centre, Miraj, 
India.
tAssociate professor and head, department of 
thoracic and cardiovascular surgery, Miraj Med­
ical Centre.
+Associate professor in medicine, medical super­
intendent and chest physician, Wanless Chest Hos­
pital and Miraj Medical Centre.
Reprint requests to: Dr. P. B. Das, Department of 
thoracic and cardiovascular surgery, Miraj Med­
ical Centre, Miraj 416410, Maharashtra, India.
lades de cette serie se sont tenues dans des 
limites acceptables. Le probleme de I'espace 
respiratoire residuel a garde des proportions 
minimales. La complication la plus grave a ete 
la fistule bronchopleurale avec empyeme (dans 
3.1% des cas) et elle a ete la cause de la plus 
forte mortality. La mortality de 2.8% est com­
parable a celle qui est rapportee dans la l i t e ­
rature. Bien que quelques malades aient pre­
sente une insuffisance respiratoire allant de 
faible a moderee, aucun d’entre eux n’a ete, 
de ce fait, gravement rendu invalide. La majo­
rity des survivants sont demeures bien portants, 
leur maladie etant enrayee. On a note la re­
activation de la pathologie chez un certain 
nombre de malades, ceci etant probablement 
attribuable a une resection trop conservatrice 
et a I'abandon de la medication antitubercu- 
leuse, sans doute par manque de comprehen­
sion entre malade et medecin.
The advent of antituberculous chemother­
apy radically altered the treatment of 
pulmonary tuberculosis.1’ 2 Effective non- 
surgical therapy has reduced the need for 
surgery and, over the past 25 years, its 
role has steadily diminished.1'4 The types 
of surgical procedures, too, have changed: 
these procedures were almost exclusively 
those producing pulmonary collapse where­
as now practically all procedures are re­
sections.2' 5 But, despite these therapeutic 
advances, tuberculosis is still a major prob­
lem in developing countries, where the in­
cidence of new cases is still high and where, 
necessarily, surgery still has a special role 
in its effective control. This paper is a 
review of the current role of surgery in the 
treatment of pulmonary tuberculosis.
Patients and T reatm ent
Between January 1963 and December 
1972, inclusive, 9939 new cases of pul­
monary tuberculosis were recorded among 
patients hospitalized at the Wanless Chest 
Hospital and Miraj Medical Centre, Miraj, 
India. The keystone of management of these 
patients was chemotherapy; this was effec­
tive in 9134 patients (91.8%). Only 805 pa­
tients (8.2%) needed surgical intervention,
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Fig. 1.—Annual numbers of admissions and 
types of treatment.
Fig. 1 presents information concerning an­
nual new case rates and also the use of 
different modalities of treatment. Notable 
is the small increase in the numbers of new 
cases seen each year and the much greater 
decrease in the number of patients requiring 
operation; in 1963, 719 patients were ad­
mitted and 189 were treated surgically, 
whereas in 1972, 1220 patients were admit­
ted but only 15 patients were treated sur­
gically.
Among the 805 patients who underwent 
a surgical procedure there were 628 males 
(78%) and 177 females (22%) (male:fe-
TABLE I.—Age Distribution of P atients 
T reated Surgically
Age No. (and %) of
(yr) patients
0 - - 10.......................... ........  0
11 - - 2 0 .......................... ........  112 (14)
21 - - 3 0 .......................... ........  403 (50)
31 - - 4 0 .......................... ........  177 l22)
41 - - 5 0 .......................... ........  97 (12)
51 - - 6 0 .......................... ........  16 ( 2)
T o ta l................. ........  805
male ratio, approximately 3.5:1). Their age 
distribution is given in Table I.
In all patients, after a course of anti­
tuberculous chemotherapy had been given 
for at least 6 months, surgical therapy was 
considered for those in whom standard in­
dications were recognized. These indications 
included persistent, thick-walled cavities, 
large residual foci of caseation or tuber­
culomas, unilateral destruction of lung tis­
sue, persistent positive sputum with drug 
resistance, bronchiectasis and bronchosteno­
sis (Figs. 2 to 4). A few patients underwent 
procedures for tuberculous bronchopleural 
fistula with empyema and some were treated 
surgically when a neoplastic condition could 
not be excluded. A few emergency resec­
tions were also performed in patients with 
persistent and life-threatening hemoptysis.
Pulmonary resection was the procedure 
of choice whenever possible; there were 663 
pulmonary resections as opposed to 142
Fig. 2a Fig. 2b
Fig. 2.—Destruction of left lung, bronchostenosis and giant cavity of left upper lobe, (a) Postero- 
anterior radiograph; (b) subsequent bronchogram.
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Fig. 3.—Destruction of left lung. Patient re­
quired pneumonectomy.
thoracoplasties. Pulmonary resections in­
cluded 298 lobectomies, 233 pneumonecto­
mies and 132 segmental resections. With 
respect to thoracoplasties, very few such 
procedures have been done in recent years.
The results of surgery are analyzed in 
Table II. Among the 782 surviving patients 
the complication rate was low. The period 
of follow-up ranged from 2 to 12 years. In 
those with reactivation of disease, resection 
was probably conservative, particularly when 
a segmental resection was performed. In 
addition, misunderstanding sometimes led 
to the impression that surgical treatment
TABLE II.—Survival and Results of Surgical 
T reatment in 805 Patients
No. (and %) of
Status patients
Survived...................................  782 (97.2)
Died.........................................  23 ( 2.8)
Bronchopleural fistula with
empyema..............................  25 ( 3.1)
Reactivation of disease...........  21 (2 .6)
Respiratory insufficiency
(mild to moderate)*............. 57 ( 7.1)
*Mild — dyspnea after walking 450 m; moderate 
— dyspnea after 180 m; severe — dyspnea even 
at rest.
had been curative and no chemotherapy 
was required.
Discussion
Changing attitudes in the surgical man­
agement of pulmonary tuberculosis over the 
past 25 years have been the direct outcome 
of highly successful antituberculous drug 
therapy.3 In developed countries, the in­
cidence of tuberculosis has steadily declined 
over the years and highly successful non- 
surgical regimens have greatly reduced the 
need for surgery.1"4 In developing coun­
tries, however, tuberculosis is still wide­
spread; the incidence of new cases of 
tuberculosis is still quite high and surgical 
treatment still is required for its effective 
control.
The male:female ratio of approximately 
3.5:1 among patients in this series is in 
disagreement with the findings of Singh and
Fig- 4a Fig. 4b
Fig. 4.—Fibrocaseous disease of left lung with persistent positive sputa before pneumonectomy (a) 
and appearance after pneumonectomy (b). ’
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colleagues.6 Surgical intervention was more 
frequent in potentially productive patients 
aged 20 to 40 years to eradicate the disease 
in the shortest possible time, thus minimiz­
ing the loss of manpower resulting from the 
protracted course and prolonged treatment 
of tuberculosis.
Although currently the tendency is for 
the physician to offer surgical treatment 
even to those patients in whom antituber­
culous drug therapy does not rapidly halt 
the disease or in whom social, economic, or 
other factors militate against its success,4 
we do not subscribe to this radical approach 
and prefer to give a fair trial to nonsurgical 
therapy for at least 6 months. Antituber­
culous drugs formed the mainstay of treat­
ment of all 9939 patients in this series and 
a surgical procedure to supplement drug 
therapy was necessary in only 8.2% of 
them. This proportion is similar to that re­
ported by Shields, Fox and Lees2 (9%) and 
much higher than that reported by Feltis 
and Campbell7 in children (2.5%) A sur­
gical rate of 15% has been reported as 
being acceptable.1
The type of surgical procedure has 
changed over the years and pulmonary re­
section has become the procedure of 
choice.1"4 Open cavities, filled cavities (no­
dular disease), bronchiectasis and other 
forms of residual disease are the usual le­
sions treated by resection, and to this one 
can add drug resistance, disease in unre­
liable and uncooperative patients, any sus­
picion of a neoplasm and the presence of 
infection with an atypical mycobacterium.4 
Before the advent of effective antituber­
culous drug therapy, pulmonary resection 
was considered to be dangerous, but anti­
microbial therapy and improved surgical 
techniques have today made pulmonary re­
section safe; indications for resection have 
widened, and fewer patients undergo col­
lapse therapy. Similarly there are now few 
indications for thoracoplasty; these indica­
tions include thin-walled upper-lobe cavities 
(Fig. 5) and bronchopleural fistulas with 
empyema (primary or postoperative), and 
thoracoplasty is sometimes used as supple­
ment to pulmonary resection.
The most common surgical procedure 
was lobectomy, followed by pneumonec­
tomy and segmental resection. Though the 
trend has been to preserve lung tissue as 
far as practicable, we have been increasing­
ly reluctant to perform segmental resection, 
which is time-consuming and is fraught with 
complications. Besides, there is always the 
likelihood of foci of active disease remain­
ing. Reactivation of disease among patients 
in the series resulted from conservative re­
section and misunderstanding between pa­
tients and physicians.
Of the resectional procedures, lobectomy 
appears to be associated with the most un­
eventful postoperative course, except for the 
occasional patient with a problem of residu­
al space, which can be overcome by vigor­
ous preoperative and postoperative physio-
Fig. 5a Fig. 5b
Fig. 5.—Cavity of right upper lobe (a) and appearance after thoracoplasty (b).
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an emerging problem
Bacteroides species are often over­
looked as a cause of serious infec­
tion both by clinicians and micro­
biologists. They are most commonly 
associated with intra-abdominal 
and pelvic sepsis following gastro­
intestinal surgery.”
Tracy, 0 .,e t  al.(29 Jan.’72).
Brit. med.J.,p. 280.
“Our experience with this series of seriously 
ill patients provides clinical confirmation to 
complement recent in vitro evidence that 
clindamycin is the antibiotic of choice for 
use in bacteroides infections. Not only was 
the response in 17 of the 18 patients favour­
able, but in several it was dramatic.”
Haldane, E. V. and van Rooyen, C. E. (1972).
C.M.A.J.,p.1177.
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bacteroides infection
•  I.M. injection or I.V. infusion 
achieves prompt and high peak 
serum levels of active clindamycin
•  well tolerated locally and sys- 
temically following I.M. injection 
or I.V. infusion
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If significant diarrhea occurs during therapy, this drug should be 
discontinued or, if necessary, continued only with close observation. 
Significant diarrhea occurring up toseveral weeks post-therapy should 
be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing 
minimal mucosal changes may respond to simple drug discontin­
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Anticholinergics and antiperistaltic agents may worsen the condition. 
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tosis, nausea, diarrhea, changes in blood pressure, shortness of breath 
and bad or bitter taste in mouth have been reported.
Not indicated in patients who have demonstrated sensitivity to clin­
damycin or lincomycin. Safety in infants below 30 days of age or 
in pregnant women not established. Use with caution in patients 
with a history o f asthma and other allergies. As with other antibiotics, 
periodic liver function tests and blood counts should be performed 
during prolonged therapy.
Detailed information available upon request.
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cin-2-phosphate equivalent to clindamycin base 150 mg in 2 ml and 
1 ml paediatric ampoules.
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therapy, endotracheal and bronchoscopic 
suction to remove secretion and to expand 
the lung. Having patients blow up a foot­
ball bladder or blow into bottles has also 
been of great help. If the space problem can 
be anticipated preoperatively, a concomitant 
limited thoracoplasty may be helpful.
The incidence of bronchopleural fistula 
with empyema (3.1%) is comparable to the 
rates reported in the literature. The man­
agement of this problem consisted of thora­
costomy tube drainage and then thoraco­
plasty. A few patients were treated with 
open drainage by creation of a window, 
with good results.4- 8
The mortality of 2.8% among the pa­
tients in this series compares favourably 
with that reported by Neptune, Kim and 
Bookwalter1 (1.3% ) and that reported by 
Shields, Fox and Lees2 (1.3%) and is much 
lower than the mortality given in other 
Indian reports: Singh and colleagues6 re­
ported a mortality of 11% and Betts and 
associates 12%.6
Respiratory insufficiency of varying de­
grees was confined to patients who un­
derwent pneumonectomy and those with 
borderline pulmonary function. This was 
overcome by change of vocation and proper 
rehabilitation. In the overwhelming majority 
of the 782 surviving patients, the disease 
has remained under control.
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EXPERIENCE WITH SURGICAL SALVAGE IN PULMONARY 
TUBERCULOSIS: APPLICATION TO GENERAL THORACIC SURGERY
NORMAN C. DELARUE, MD,* F. G. PEARSON, MD,* R. D. HENDERSON, MD,* 
J. D. COOPER, MD,* J. M. NELEMS, MD* and GODFREY GALE, MDt
Summary: The diminishing incidence of pul­
monary tuberculosis and the increasing ef­
fectiveness of drug therapy have resulted in an 
almost complete disappearance of surgical prob­
lems in the management of patients with this 
disease. However, the lessons learned from the 
management of such problems should not be 
forgotten, for they are equally applicable to the 
management of disabling and life-endangering 
problems in general thoracic surgical practice.
"Salvage” situations develop when therapeutic 
requirements for control of disease are com­
bined with factors affecting a patient's health 
so as to increase the surgical risk beyond the 
range usually considered acceptable. Attempts 
to salvage patients are indicated when treat­
ment has failed to arrest disease, when life ex­
pectancy is threatened, or when return to nor­
mal activity is imperilled. Risk may be increased 
because of age, inadequate cardiopulmonary 
reserve, or chronic toxemia; in tuberculosis, 
risk may be increased because of positive 
sputum culture or resistance of organisms.
Experience with 146 tuberculous patients has 
provided a basis for evaluation of the indications 
for resection, prophylactic and therapeutic 
thoracoplasty, and closure of bronchopleural 
fistulas in general thoracic surgical salvage. 
Both infection in residual spaces and broncho­
pleural fistulas are serious complications that 
can be controlled by thoracoplasty and pedicled 
muscle grafts. Prophylactic use of osteoplastic 
thoracoplasty and intercostal muscle grafts war­
rant more serious consideration. In established 
complications a “tailored" thoracoplasty can al­
so be combined with an intercostal muscle 
graft.
Resume: Nous constatons actuellement la dis- 
parition quasi complete des problemes chirur- 
gicaux poses par la tuberculose pulmonaire. 
Ceci est du surtout a la moindre frequence de 
cette infection, elle-meme attribuable a I'effica 
cite remarquable des medicaments anti-tuber- 
culeux. {.'experience chirurgicale acquise autre­
fois dans ce domaine ne devrait cependant pas
♦Division of thoracic surgery, Toronto General 
Hospital, Toronto, Ont.
tToronto Hospital, Weston, Ont.
Reprint requests to: Dr. N. C. Delarue, Suite 
530, 170 St. George St., Toronto, ON M5R 2M8.
etre negligee, car elle demeure applicable au 
traitement des cas rencontres en pratique chi­
rurgicale thoracique generale, principalement des 
cas susceptibles de provoquer une invalidity 
permanente ou de mettre en danger la vie des 
malades.
Ces situations critiques surviennent quand 
les traitements necessaires pour combattre la 
maladie se combinent avec des facteurs qui af­
ferent la sante du patient au point d’augmenter 
le risque chirurgical au-dela d'un point generale- 
ment considere comme acceptable. Les tentati- 
ves de sauver les malades sont indiquees dans 
les cas suivants: echec du traitement con$u 
pour enrayer 1'evolution de la pathologie, mena­
ce a I’esperance de vie, mise en peril du retour 
a une vie normale. D'autres facteurs peuvent 
aggraver le risque: age du malade, reserve car- 
diopulmonaire insuffisante, toxemie chronique. 
Dans la tuberculose, une culture positive des 
crachats ou la resistance du micro-organisme a 
la medication peuvent aussi augmenter le risque.
Pour evaluer les indications d’une resection 
eventuelle, d'une thoracoplastie prophylactique 
ou therapeutique et la fermeture de fistules 
bronchopleurales dans le domaine des opera­
tions du sauvetage en chirurgie thoracique, on 
s'est base sur (’experience acquise chez 146 
tuberculeux. L'infection qui s'installe dans des 
espaces residuels et des fistules broncho-pleu- 
rales sont des complications redoutables qui 
peuvent etre traitees efficacement par une tho­
racoplastie et des greffes musculaires pedicu- 
iees. Le recours prophylactique a une thoraco­
plastie osteogenique et a des greffes de muscles 
intercostaux devrait etre considere plus atten- 
tivement. Dans des complications bien etablies, 
on peut egalement associer une thoracoplastie 
judicieusement calculee a une greffe de muscle 
intercostal.
As drug treatment becomes more effective 
and the nutritional status of potential pa­
tients improves, the indications for surgical 
treatment in pulmonary tuberculosis have 
almost completely disappeared. This trend, 
although beneficial in every way for the tu­
berculous patient, poses difficult problems in 
the training of thoracic surgeons, for the 
various technical maneuvers once relatively 
frequent in the management of tuberculous 
disease can no longer be taught to residents,
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Nontuberculous disease, however, still pre­
sents similar problems in management—al­
though they occur uncommonly— and con­
sequently the techniques that were developed 
and perfected in the treatment of complica­
tions of pulmonary tuberculosis must not 
be forgotten.
Most of the important lessons were 
learned when surgical treatment became the 
only remaining potential form of controlling 
tuberculosis in patients in whom, for various 
reasons, the risk of surgical treatment would 
ordinarily have been considered prohibitive. 
In large part, “salvage” procedures of this 
type were required in patients with persistent 
infection in unobliterated spaces; broncho­
pleural fistulas were frequently associated 
complications. Although today there is less 
need for surgical salvage, the experience 
gained in managing these complicated prob­
lems can be used effectively in managing 
similar problems that develop in general 
thoracic surgical practice. This paper is a 
review of the lessons that should be recalled.
Complications of Salvage R esection
in Tuberculosis
A previous report1 evaluated 55 salvage 
resections. Resistant organisms were cultured 
from 65% of the patients, a persisting 
cavity was found in 85% and the sputum 
was positive in 80% (Table I). These bac-
TABLE I.-—F indings Associated with Chemo­
therapy Failure in 55 P atients with P ulmonary 
T uberculosis
teriologic findings explained the ever-present 
spectre of “spread”, which developed in 7 
(13%) of the 55 patients. Despite these 
features, postoperative mortality was only 
9% and the tuberculous disease was con­
trolled in 85% of the patients; long-term 
rehabilitation was successful in 51 % of the 
patients. As anticipated, however, the com­
plication rate was appreciable, complica­
tions occurring in 49% of the patients. The 
incidence of bronchopleural fistula was 
alarming; it occurred in 20%. Moreover, 
the occurrence of the bronchopleural fistula 
in these patients was a serious development: 
54% of them (6 of 11) died in the early 
postoperative period (Table II)— and in all 
of these patients death was due to the fistula 
or to the associated uncontrolled tubercu­
losis.
Consequently, the management of bron­
chopleural fistula, whether it be preventive 
or definitive, becomes of paramount im­
portance. Ideally, of course, every attempt 
should be made to prevent this complication, 
but when this ideal objective is not achieved, 
the treatment of the established fistula must 
be effective and accomplished easily in dif­
ficult circumstances.
Management of Bronchopleural
F istula
The management of bronchopleural fis­
tulas comprises preventive measures and 
definitive treatment for the established fis­
tula.
Findings No. of patients
Persisting cavity.......................... 47
Positive sputum........................... 44
Resistant organisms....................  36
Positive empyema aspirate......... 2
Prevention
Effective closure of the bronchus depends 
on four factors: (a) preservation of ade­
quate blood supply to the bronchial stump; 
(b) careful and meticulous suture; (c) ab-
TABLEII.—P ostoperative Bronchopleural F istulas (Pulmonary Tuberculosis)
No. of 
patients
Survival status Cause of death
Management Alive Dead Early Late
Expectant
Spontaneous closure.... 
“Spread” of tuberculosis
1
2
1
2 Tuberculosis 
in both
Empyema drainage.......... 5 1 4 Pyogenic inf., 3; 
tuberculosis, 1
Thoracoplasty................... 3 1 2 Tuberculosis, 1; 
cor pulmonale, 1
Total................................. 11 3 8 6 2
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sence of infection; and (d) coaptation of 
viable tissue.
The importance of contact of viable tissue 
with the stump is frequently overlooked. 
This is attested to by the fact that the 
persistence of pleural spaces after resection 
is associated with an increased incidence 
of fistulas—as, for example, when the ex­
cision of too much lung means that the re­
maining lung may be incapable of obliterat­
ing the pleural space. This risk was well 
demonstrated in our initial experience with 
the combined procedure of left upper lobec­
tomy and apical segmental resection of the 
left lower lobe.1 Among eight tuberculous 
patients- in whom this combined procedure 
was done, fistulas developed after operation 
in five.
The lung may also be incapable of ex­
panding adequately when it is fibrotic be­
cause of diffuse disease such as chronic 
inflammatory change; inadequate expansion 
may occur after pulmonary resection when 
the remaining lung is emphysematous and 
already maximally distended.
Therefore, if the expansion capability of 
the lung is suspect, one must make the 
thoracic cage fit the lung rather than expect 
the lung to fill a space that it is quite in­
capable of obliterating. This can be done 
in one of several ways:
1. Use of pleural “tents”. However, when 
resection is necessary in cases of chronic 
inflammation and when inadequate expan­
sion may be anticipated, the parietal pleura 
has usually been damaged irretrievably by 
the need for extrapleural dissection. Use of 
the tent may be a reasonable alternative in 
operations on emphysematous lungs if the 
intact pleural surface can be preserved and 
if it is firm enough to be sutured securely in 
place.
2. Preparation of a Marlex roof. One 
hesitates, however, to insert a foreign body 
in potentially infected fields.
3. Temporary crush of the phrenic nerve 
immediately above the diaphragm. Such a 
procedure, with or without a complementary 
pneumoperitoneum, is useful in lower lobe 
resection, but recovery of diaphragmatic 
function cannot be guaranteed.
4. Diaphragmatic reimplantation at a 
higher level. This is neither difficult nor 
particularly time consuming, but the peri­
toneal cavity is opened and this, with any 
infection, creates an increased risk. In ad­
dition, the stretched diaphragm does not 
recover fully its effective function as a bel­
lows.
5. Use of concomitant osteoplastic 
thoracoplasty. In contrast to the first four 
procedures, osteoplastic thoracoplasty is 
simple and effective, adds little to operative 
stress, and immediately controls paradox. 
Its application in general thoracic surgical 
procedures has not found the favour it de­
serves.
Figs. 1 to 4 illustrate the uneventful post-
Jan. 10, 1961 June 24, 1961 Apr. 4, 1974
Fig. 1.—Extensive resection for tuberculosis and concomitant osteoplastic thoracoplasty. Summary of 
history: 1946 (age 19)—therapeutic L pneumothorax for pulmonary tuberculosis; Jan. 10, 1961—positive 
sputum and chronic fibrotic disease of RUL; June 14, 1961—R upper lobectomy, R middle lobectomy, 
plication apical segment RLL (emphysema), and five-rib osteoplastic thoracoplasty (prophylactic); 
(June 16, 1961—tracheostomy (secretional stasis) but convalescence otherwise uneventful; Nov. 16, 1964 
—bronchoscopy for hemoptysis, granulation around Mersilene suture; Apr. 5, 1974—mastectomy for 
carcinoma R breast, but no chest complaints.
522 THE CANADIAN JOURNAL OF SURGERY Vol. 18
June 30, 1961 Aug. 19, 1969
Fig. 2.—Resection in presence of infection and immediate space obliteration by osteoplastic thora­
coplasty. Summary of history: 1940 (age 19)—therapeutic R pneumothorax for pulmonary tuberculosis-
June 1961—bronchopleural fistula, empyema, multiple abscesses RUL; July 13, 1961_enucleation
empyema, R upper lobectomy, osteoplastic thoracoplasty (prophylactic), with uneventful recovery 
August 1973—alive and well.
operative course of patients treated by osteo­
plastic thoracoplasty. In these patients early 
obliteration of the pleural space was gua­
ranteed by reducing the volume of the hemi- 
thorax that the lung with limited capacity 
for expansion had to fill. The uneventful 
postoperative course of these patients dif­
fers greatly from that encountered when the 
life-endangering complications of infection
and bronchopleural fistula develop in un­
obliterated spaces during the early post­
operative period (Figs. 5 and 6).
Treatment
Once a bronchopleural fistula is estab­
lished, effective closure usually requires the 
application of a vascularized graft to the
Aug. 24, 1961 Sept. 7, 1961 May 26, 1973
, .  Fig%nTT^eSecti??  P r in c e  of infection and concomitant osteoplastic thoracoplasty. Summary of 
history: 1954 (age 36)—fibrosis and retraction RUL with pleural thickening (no evidence of tuberculo­
sis); April 1961—pneumonia with abscess RUL; August 1961—bronchopleural fistula with empye­
ma (arrow) (Bacillus pyocyaneus); Sept. 26, 1961—extrapleural empyemectomy, R upper lobectomv
osteoplastic thoracoplasty (prophylactic), with uneventful recovery; May 1973__alive and well tar-
rows mark herniation of lung). v
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Apr. 24, 1967 Oct. 28, 1967 July 3, 1973
Fig. 4.—Bilateral resection for bullous emphysema with inadequate remnant of left lung and 
osteoplastic thoracoplasty. Summary of history: 1952 (age 38) and 1964—bilateral bullous emphy­
sema, spontaneous pneumothorax; Oct. 23, 1967—peripheral plication RLL, assisted ventilation postop- 
eratively; Mar. 14, 1967—pharyngoesophageal myotomy and drainage for pharyngoesophageal diver­
ticulum and dysphagia; February 1973—increasing dyspnea .and radiographic changes on L; Feb. 23, 
1973—excision tension cysts and plication LLL, osteoplastic thoracoplasty (prophylactic), with un­
eventful course; July 3, 1973—working (farmer).
resutured bronchial stump. Accumulated 
experience suggests that applying vascular­
ized, pedicled muscle grafts is the most ef­
fective method of securing the closure. 
Grafts of pectoral muscles, the latissimus 
dorsi, the teres major and the subscapularis
have all been used, but the ready availability 
of the intercostal muscle bundle makes this 
muscle preferable.
The frequency with which these estab­
lished fistulas are associated with persisting 
spaces underlines the need to obliterate the
Dec. 16, 1966 Jan. 23, 1973
Fig. 5.—Segmental resection with postoperative air leak and early osteoplastic thoracoplasty with in­
tercostal muscle bundle graft to fistulas. Summary of history: 1966 (age 36)—cavitary tuberculosis 
LUL; May 26, 1967—apical posterior segmental resection LUL with persistent air leak, and early 
reoperation to prevent empyema; June 2, 1967—osteoplastic thoracoplasty (therapeutic) using single 
intact intercostal muscle bundle graft to multiple air leaks, with uneventful course; 1973—alive and 
well. Arrows mark first rib.
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Sepf. 13, 1968 Nov. 16, 1968 Oct. 20, 1969
Fig. 6.—Resection in bullous emphysema with inadequate expansion of residual fibrotic lung (ar­
row) and osteoplastic thoracoplasty. Summary of history: 1968 (age 55)—severe dyspnea (increasing 
since 1965), focal tension bullous emphysema RUL; Nov. 4, 1968—R upper lobectomy, excision 
bullae and plication RLL, with air leak and residual space necessitating care in respiratory failure 
unit; Nov. 18, 1968—osteoplastic thoracoplasty (therapeutic), with uneventful course; 1970—nor­
mal daily activity.
space when the fistula is closed with the 
intercostal bundle graft. The uninfected 
space, which frequently exists when early 
postpneumonectomy fistulas develop, is an 
exception to this generalization; resuture of 
the bronchial stump then may require only 
the additional protection of a pedicle graft 
without space obliteration (Fig. 7).
Experience with salvage procedures in 
patients with pulmonary tuberculosis in­
dicated that obliteration of the space could 
best be accomplished by the “tailored” 
thoracoplasty when decortication was not 
technically feasible. This type of procedure 
was undertaken in 37 patients with tuber­
culous disease. In these patients the indica­
tions were primarily those of chronic em­
pyema. A bronchopleural fistula developed 
in 11 of the 37 patients (10 fistulas developed 
among 16 patients who had undergone re­
section and 1 developed among 3 patients 
treated by oleothorax). Approximately 
60% of the patients were rehabilitated 
completely and 10 of the 11 bronchopleural 
fistulas were closed successfully. The re­
maining patient with a bronchopleural fis­
tula died postoperatively from staphylococcal 
septicemia before it was possible to decide 
whether the fistula itself had been success­
fully closed.
July 24, 1973 Aug. 6, 1973 Aug. 6, 1973
Fig. 7.—Postpneumonectomy bronchopleural fistula (early) treated by immediate closure with 
intercostal muscle bundle graft; no drainage. Summary of history: July 24, 1973 (age 53)__R pneu­
monectomy for bronchogenic carcinoma; July 26, 1973—bronchopleural fistula detected and second­
ary closure of bronchial stump with intercostal muscle bundle graft; August 1973__uneventful
recovery.
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The tailored procedure not only proves 
effective in obliterating the space but also 
obviates the disabling weakness of the ab­
dominal wall that is associated with proce­
dures in which the intercostal muscle bun­
dles with their intercostal nerves are not 
preserved. The surgical technique has been 
described previously.2
With respect to the application of these 
principles to the management of general 
thoracic surgical problems, Figs. 8 to 10 
demonstrate how, in general, experience in 
the treatment of tuberculosis can be ap­
plied to problems of general thoracic sur­
gery. In all patients except those in the early 
stages after pneumonectomy the combina­
tion of a bronchopleural fistula with infec­
tion in a residual space demands a proce­
dure not only to close the fistula but also to 
obliterate the space at the same time.
Bronchopleural fistulas may develop spon­
taneously or follow partial or total removal 
of the lung. When they occur as a result of 
infection in the lung or after segmental re­
section or lobectomy they may be single 
or multiple. Single or multiple, fistulas on 
the surface of lung tissue are best treated by
suture closure. The single fistula, once 
sutured, is then covered by an intact muscle 
bundle held in place as recommended for 
major bronchial fistulas.1 Multiple leaks 
are controlled in the same way by fashion­
ing a lattice of several intercostal bundles 
over the affected surface.
Development of a fistula after pneumo­
nectomy presents special problems because 
of the size of the space to be obliterated and 
the amount of fluid that can be aspirated 
through the fistula. If a fistula develops im­
mediately after operation, before infection 
becomes an important factor, the technical 
complication can be managed by reclosure 
of the bronchial stump, which is then pro­
tected by an intercostal muscle graft and the 
wound promptly closed (Fig. 7.) If there is 
a frank tuberculous empyema, the combina­
tion of fistula closure and tailored thora­
coplasty is well tolerated because, in the 
chronic stage, paradox is not an important 
complication and the intercostal nerves are 
preserved. With pyogenic infection, how­
ever, the extensive deformity may be 
avoided by fistula closure and creation of a 
thoracostomy stoma that permits irrigation
Oct. 31, 1972 Mar. 1, 1973
Fig. 8.—Tuberculous empyema and multiple bronchopleural fistulas treated by “tailored” thora­
coplasty and multiple intercostal bundle grafts. Summary of history: 1941 (age 24)—R therapeutic 
pneumothorax, pneumolysis and oleothorax; 1947— aspiration of sterile oleothorax; December 1971— 
bronchopleural fistula, evacuation of oleothorax; August 1972—positive sputum, INH therapy; Sep­
tember 1972—empyema fluid culture positive, therapy with streptomycin, ethambutol and rifampin; 
Dec. 13, 1972—seven-rib “tailored” thoracoplasty, multiple intact intercostal muscle bundle grafts for 
multiple bronchopleural fistulas, with uneventful course; December 1973— alive and well.
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Mar. 10, 1958 
Fig. 9a
Mar. 25, 1958 
Fig. 9b
June 26, 1958 Mar. 25, 1966
Fig. 9c Fig. 9d
Fig. 9.—Postpneumonectomy bronchopleural fistula and empyema treated by tailored thoraco­
plasty and intercostal muscle bundle graft to secondary closure of bronchial stump. Summary of his­
tory: 1937 (age 23)—-R pneumothorax for pulmonary tuberculosis; 1957—acute tuberculous empyema; 
February 1958—spontaneous bronchopleural fistula, and spread of disease to L lung; Mar. 10, 1958— 
extrapleural pnemonectomy (enucleation of empyema), with postoperative bronchopleural fistula; 
June 26, 1958—nine-rib tailored thoracoplasty and intercostal muscle bundle graft for secondary closure 
of bronchial stump; 1973—alive and well.
until the infection has been eradicated. The 
implanted intercostal bundle remains a 
healthy graft under these circumstances (Fig.
11) and subsequent wound closure may 
then prove possible.
Obviously, development of a postpneu­
monectomy fistula can sometimes be anti­
cipated. And because a fistula is life-threat­
ening, an attempt should be made to prevent
this complication when it is likely to occur; 
for example, in technically difficult closures, 
when there is frank infection, or when heal­
ing has been impaired by previous irradia­
tion.
With respect to radiation-impaired heal­
ing, evidence indicates that irradiation is 
not without risk. Experience with radio­
therapy given before operations for breast
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Sept. 25, 1973 Dec. 3, 1973 Jan. 7, 1974
Fig. 10a Fig. 10b Fig. 10c
Feb. 11, 1974 Feb. 11, 1974 July 25, 1974
Fig. lOd Fig. lOe Fig. lOf
Fig. 10.—Multiple postoperative bronchopleural fistulas and empyema treated by tailored thoraco­
plasty and multiple intercostal muscle bundle grafts to fistulas. Summary of history: December 1971 
(age 44)—chunky lesion RLL, positive tuberculin skin test and antituberculous drug therapy; Sep­
tember 1972 to September 1973—fluctuating excavation and refilling of cavity in RLL (occasional air 
crescent [arrows, a] suggesting aspergilloma), intermittent wheezing together with brownish sputum 
and hemoptysis, and multiple bronchial communications (arrow, b) on bronchogram; Jan. 9, 1974— 
segmental resection apex RLL and wedge resection posterior segment RLL, with massive air leak post- 
operatively; Feb. 11, 1974—five-rib tailored thoracoplasty (arrows, d and e; numbers in e indicate 
ribs) and multiple intact intercostal muscle bundle grafts to multiple bronchopleural fistulas, with un­
eventful recovery; July 1974—full-time work.
cancer demonstrated the need to post­
pone a surgical procedure until the 
radiation reaction had subsided. In the in­
itial use of preoperative radiation (4500 to 
6500 rads) in 15 patients with lung cancer, 
the irradiation was given over 4 to 8 weeks, 
and no complications occurred. When, in 
16 patients, therapy was concentrated for 
increasing radiation effect (4000 rads in 
3 weeks), two fistulas did develop, and both 
proved lethal. Consequently, the treatment 
program has been adjusted and surgical 
treatment delayed until there is assurance 
that the reaction has indeed subsided. The 
bronchial stump is then covered with a 
graft of living tissue, use of the intercostal 
muscle bundle apparently being the simplest 
method of accomplishing this further pro­
tection (Fig. 12). Since these precautionary 
measures have been implemented, no fistulas 
have developed in 12 patients and it has 
been considered safe to continue using this 
form of radical combination therapy in 
selected cases.
Conclusions
The risk to life imposed by the existence 
of a bronchopleural fistula accompanied by 
infection in a persisting pleural space de­
mands that these thoracic surgical complica­
tions be avoided, if possible. The techniques 
for fistula closure and obliteration of the re­
sidual space that were developed as part of 
the treatment of patients with pulmonary 
tuberculosis can be applied effectively to 
similar problems in general thoracic surgical
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May 10, 1971 Sept. 25, 1971 Oct. 6, 1971
Fig. 11.—Postpneumonectomy bronchopleural fistula (delayed) treated by secondary closure with 
intercostal muscle bundle graft; permanent drainage. Summary of history: Apr. 22, 1971 (age 59)—R 
pneumonectomy for bronchogenic carcinoma; June 1971—small bronchopleural fistula visualized, but 
surgical treatment refused; August 1971—bronchopleural fistula demonstrated by contrast medium, 
and increasing air in pleural space; September 1971—secondary closure of bronchopleural fistula with 
intercostal muscle bundle graft and pleurocutaneous window; October 1971—fistula firmly closed and 
pleural space sterile (thoracoscopy), but patient refused closure of thoracostomy; 1972—open thora­
costomy window draining well, and patient active. Numbers indicate ribs, arrows outline intercostal 
muscle graft.
practice. The procedures are technically sim­
ple. The intercostal muscle bundle, which 
is almost always available, is an effective 
graft for protection when a fistula is being 
closed, and the tailored thoracoplasty with 
preservation of intercostal bundles can be 
used equally well for obliteration of the 
chronically infected pleural space.
The surgical challenge is now clear. In­
creasing use must be made of definitive 
procedures for prophylactic treatment when 
complications can be anticipated. The osteo­
plastic thoracoplasty, which provides imme­
diate chest wall stability, can be used when 
a persistent space is to be anticipated and 
the intercostal muscle bundle graft when the 
possibility of a major bronchial fistula has 
to be seriously considered.
References
1. Delarue NC, Gale G: Surgical salvage in
pulmonary tuberculosis. Ann Thorac Surg 
18: 38, 1974
2. Kergin FG: Operation for chronic pleural em­
pyema. /  Thorac Surg 26: 430, 1953
Feb. 15, 1974 Mar. 13, 1974 July 15, 1974
Fig. 12.—Bronchogenic carcinoma treated by preoperative radiotherapy and postirradiation pneu­
monectomy with prophylactic coverage of bronchial stump with intercostal muscle bundle graft. Sum­
mary of history: Feb. 11, 1974 (age 55)—ipsilateral intranodal superior mediastinal metastatic squamous 
carcinoma (primary bronchogenic carcinoma of R lung) revealed by mediastinoscopy; May 13, 1974 
—R radical pneumonectomy and intercostal muscle bundle graft to protect bronchial stump; August 
1974—uneventful recovery.
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GROWTH OF COMMON BACTERIA AND CANDIDA ALBICANS 
IN 10%  SOYBEAN OIL EMULSION*
MERVYN DEUEL, MD, FRCSfC], FACS, FICS,t VICTOR 
M. KAMINSKY, MB, FRCS(Edin) and MILAN FUKSA, ScD±
Summary: Bacterial and fungal growth in 10% 
soybean oil emulsion (Intralipid) and 5% fibrin 
hydrolysate in 5%  dextrose was studied at 4, 25
and 37 °C. Staphylococcus aureus, Streptococ­
cus pyogenes, Str. fecalis, Pseudomonas aeru­
ginosa, Klebsiella pneumoniae, Escherichia coli 
and Candida albicans were grown in broth at 
37°C, diluted in saline and inoculated into each 
of the two preparations as well as a mixture of 
the two. Growth was measured at 24, 48 and 
72 hours.
In 10% soybean emulsion, all bacteria except 
S. pyogenes multiplied, but in fibrin hydroly­
sate-dextrose solution the only organism of 
those studied to grow was S. aureus. In the 
hydrolysate-dextrose-lipid mixture, all organisms 
multiplied except S. pyogenes and P. aeruginosa. 
C. albicans grew in all solutions tested. While 
at 4°C, organisms did not multiply.
The fibrin hydrolysate-dextrose solutions given 
by infusion into a central vein for hyperalimenta­
tion have been shown to support predominantly 
fungal growth, and contamination of the solution 
and ultimately of the indwelling catheter is a 
constant hazard. Because both bacteria and 
C. albicans grew equally well in 10% soybean 
oil emulsion, its use as a caloric source when 
infused into a central vein may increase the 
occurrence of sepsis. When this emulsion is 
used to provide essential fatty acids or calories, 
it should be given via a peripheral vein, so that 
a central catheter will not be contaminated.
Resume: Nous avons etudie aux temperatures 
de 4, de 25 et de 37°C, la pousse bacterienne 
et la croissance de champignons dans une emul­
sion d’huile de soya a 10% (Intralipid) et dans 
un melange d'un hydrolysat a 5% de fibrine et 
d’une solution a 5% de dextrose. Nous avons
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cultive les micro-organismes suivants: Staphy­
lococcus aureus, Streptococcus pyogenes, Str. 
fecalis, Pseudomonas aeruginosa, Klebsiella 
pneumoniae, Escherichia coli et Candida albi­
cans dans un bouillon a 37°C, les avons dilue 
dans un serum physiologique salin et les avons 
inocule dans chacun des deux produits et dans 
un melange des deux. La pousse a ete mesuree 
apres 24, 48 et 72 heures.
Dans I'emulsion d'huile de soya a 10%, toutes 
les bacteries, a I'exception de Str. pyogenes, 
se sont multipliees, mais dans la solution com- 
posee d'hydrolysat de fibrine et de solution de 
dextrose, le seul parmi les organismes etudies 
qui ait pousse a ete S. aureus. Dans le melange 
d’hydrolysat, dextrose et lipid, tous les micro- 
organismes se sont multiplies, sauf Str. pyogenes 
et P. aeruginosa. Quant au C. albicans, il a 
pousse dans tous les produits a I’etude. Toute- 
fois, a 4°C, les organismes ne se sont pas mul­
tiplies.
La solution composee d'hydrolysat de fibrine 
et de dextrose, donnee en perfusion dans une 
veine centrale en vue d'hyperalimentation s'est 
revelee particulierement apte a favoriser la 
croissance de champignons. La contamination 
de la solution et, finalement, celle de la sonde 
a demeure, est un risque permanent. Etant don- 
ne que tant les bacteries que C. albicans, se 
multipliaient egalement bien dans I'emulsion 
d huile de soya a 10%, son usage comme 
source calorique, par voie d’une veine centrale, 
risque d'augmenter le danger d'infection. Quand 
cette emulsion est employee pour fournir d’aci- 
de gras essentiel ou des calories, elle devrait 
etre administree par une veine peripherique, 
ce qui eviterait le risque de contamination d'un 
catheter central.
In travenous  hyperalimentation (IVH), with 
hypertonic glucose as the caloric source, has 
become established in the management of 
major clinical nutritional problems.1 A 10% 
soybean oil emulsion (Intralipid) has been 
used in Europe for several years as a caloric 
source, and is given by infusion in both 
peripheral and central veins.2'3 In North 
America it has also been used both peri­
pherally6' 7 and also centrally as a partial 
caloric source.8’ 9
A common complication of IVH is septi­
cemia, of which the most serious, and fre-
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quently fatal, form is fungal septicemia.10'13 
The liquid used for hyperalimentation re­
portedly supports the growth of a variety of 
fungi and bacteria, and microbial contamina­
tion is a constant threat.14' 17 We therefore 
evaluated the growth properties of selected 
nosocomial pathogens in 10% soybean oil 
emulsion and in fibrin hydrolysate also.
M a t e r ia l s  a n d  M et h o d s
Solutions
Solutions included 10% soybean oil emul­
sion (Intralipid, Pharmacia Canada), a fibrin 
hydrolysate (5% Aminosol in 5% dextrose, 
Abbott Laboratories), and a 1:1 mixture of 
10% soybean oil emulsion and fibrin hy­
drolysate. The mixture was chosen for study 
because it forms when each preparation is 
given in separate intravenous lines, the two 
preparations uniting just before entering the 
peripheral or central vein, as often occurs 
in clinical practice.3' 8
Organisms
Seven organisms (Staphylococcus aureus, 
Streptococcus pyogenes, Str. fecalis, Pseu­
domonas aeruginosa, Klebsiella pneumoniae, 
Escherichia coli and Candida albicans) were 
isolated for study. All strains were clinical 
isolates.
Culture
All organisms were subcultured in Tryp- 
ticase Soy Broth (Baltimore Biological Labo- E 
ratories) at 37°C and diluted in sterile saline (- 
to obtain a starting inoculum of approx- |  
imately 104 to 105 colony-producing cells o 
per millilitre; the incubation times of sub- ^  
cultures and the dilution techniques were, _j 
as a preliminary, established for each organ- “  
ism to obtain the correct inoculum. A sus- >  
pension of organisms in saline of 0.1 ml was 
added to 4.9 ml of each test solution. By 
means of a 0.001 ml quantitative platinum 
loop a sample of the test solution was plated 
onto Dextrose Sensitivity Test Agar (Oxoid 
Ltd., London, UK) and incubated for 48 
hours at 37°C. Colony counts were made 
on a Fisher colony counter (Fisher Scien­
tific Co.), thus establishing a count at 
0 hours. The soybean oil emulsion and the 
fibrin hydrolysate were then incubated at
4, 25 and 37°C, and the mixture was in­
cubated at 25°C. The same technique was 
used to make at least duplicate colony counts 
of each organism at 24, 48 and 72 hours. 
When growth was luxuriant, the solutions 
were diluted further to obtain accurate 
counts. In all dilution techniques, a tube 
vibrator (Vortex Jr. Mixer) was used to 
obtain a well-homogenized organism suspen­
sion.
R e s u l t s
Incubation at 4°C
When incubated at 4°C, the organisms 
failed to multiply in both the 10% soybean 
oil emulsion and the fibrin hydrolysate- 
dextrose preparation. The organisms re­
mained viable, however, for as soon as these 
test solutions were incubated at 37 °C, mul­
tiplication recommenced.
Incubation at 25°C
When the organisms were incubated in 
10% soybean oil emulsion, all organisms 
except Str. pyogenes multiplied (Fig. 1). In 
the fibrin hydrolysate-dextrose preparation 
only C. albicans and S. aureus multiplied
Fig. 1.—Growth of organisms in 10% soybean 
oil emulsion at 2 5 °C. Solid upright triangle, 
C. albicans; solid inverted triangle, K. pneumoniae; 
open triangle, Str. fecalis; open square, P. aeru­
ginosa: solid square. Str. pyogenes; solid circle, 
S. aureus, open circle, E. coli.
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Fig. 2.—Growth of organisms in fibrin hydro- 
lysate-dextrose at 25°C. For explanation of sym­
bols see Fig. 1.
(Fig. 2). In the mixture of the two prepara­
tions all organisms except Str. pyogenes and 
P. aeruginosa multiplied (Fig. 3).
Incubation at 37°C
When the organisms were incubated in 
10% soybean oil emulsion, there was lux-
Fig. 3.—Growth of organisms in mixture of 
10% soybean oil emulsion and fibrin hydrolysate- 
dextrose at 25°C. For explanation of symbols see 
Fig. 1.
uriant growth of all organisms (Fig. 4), ex­
cept for Str. pyogenes, which failed to mul­
tiply in all of the test solutions regardless 
of the incubation temperature. In the fibrin 
hydrolysate-dextrose preparation, only C. 
albicans grew luxuriantly (Fig. 5). S. aureus, 
after a 24-hour period of growth, thereafter 
declined in growth.
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In summary, in the 10% soybean oil 
emulsion, all bacteria except Str. pyogenes 
grew; in the fibrin hydrolysate-dextrose so­
lution, of the bacteria tested, only S. aureus 
grew; and, considering growth of all organ­
isms, only C. albicans grew in all three solu­
tions.
D iscussion
Numerous sources of catheter sepsis com­
plicating IVH by the central route have 
been reported. They include the techniques 
of the attendants, frequent manipulations of 
the infusion apparatus (such as intermittent 
interruptions to infuse the 10% soybean 
oil emulsion), hematogenous catheter seed­
ing from infections in the patients them­
selves and contamination of the solution.18 
Contamination of the solution and ultimate­
ly of the indwelling catheter is a constant 
threat.15, 16 19 Deeb and Natsios14 cul­
tured IVH solution taken from 55 bottles 
before use and found all samples uniformly 
sterile, but they also found that 38% of 
samples from 85 in-use bottles were conta­
minated, which suggested that contamination 
occurs on the wards. Frequent and unne­
cessary interruptions or breaks in the closed 
tubing system during the course of central 
intravenous therapy increase the risk of con­
tamination.1416, 18
IVH with protein hydrolysate has been 
associated with rates of septicemia varying 
from 0 to 2 7% .18 Among 2078 patients 
receiving IVH at 31 hospitals with a skilled, 
team approach, the septicemia rate was 7 %; 
54% of the infections were attributable to 
infection with C. albicans.18, 19 Two stud­
ies showed that fungi have caused a much 
higher percentage of the infections.10, 12 
Fungal infections in malnourished patients 
are attributed to chronic debility, diabetes 
and therapy with broad-spectrum antibiotics, 
steroids and immunosuppressive drugs;15 
also, protein hydrolysate-dextrose solutions 
appear to favour growth of fungi over bac­
teria (Figs. 2 and 5).14-19 With a skilled, 
organized, team approach, however, the in­
cidence of septicemia can be reduced to 
less than 1% .13
The use of the 10% soybean oil emulsion 
as a partial caloric source in IVH was de­
scribed by Wei, Hamilton and LeBlanc.8
They gave this emulsion and a casein hy­
drolysate-fructose-ethanol mixture to 15 
patients through a central catheter as a 
partial caloric source, and septicemia de­
veloped in 6 patients; the bacterial to fungal 
ratio was 2:1. Zohrab, McHattie and Jee- 
jeebhoy9 used a similar technique and 
stated that the use of 10% soybean oil emul­
sion to provide part of the calories avoided 
hyperglycemia, hyperinsulinemia and hy- 
perosmolarity. They also suggested that if 
increased blood sugar concentrations are 
avoided, there may be fewer fungal infec­
tions, which have been reported when non­
protein calories were supplied solely as glu­
cose.9 However, we found that, when non­
diabetic patients or patients with controlled 
diabetes received glucose as the sole caloric 
source, blood sugar values were not appre­
ciably increased.20 In the series of Zohrab, 
McHattie and Jeejeebhoy9 most patients re­
ceived the soybean oil emulsion through a 
central vein, and septicemia developed in 3 
of 48 patients, two infections being bacterial 
and one, fungal. Thus, those who have in­
fused soybean oil emulsion through a cen­
tral venous catheter may have found a 
higher rate of bacterial sepsis than fungal 
sepsis in catheters,8, 9 in contrast to those 
who have infused protein hydrolysate-hy­
pertonic dextrose, who have found a higher 
rate of fungal than bacterial sepsis in the 
catheter.10, 12, 19
Our present bacteriologic studies have 
shown that bacteria and C. albicans multi­
plied when incubated in 10% soybean oil 
emulsion, whereas our previous and present 
studies with protein hydrolysate-dextrose 
showed that growth of C. albicans predom­
inated.15 This suggests that the use of 10% 
soybean oil emulsion as a caloric source, 
via a long-term central catheter could pos­
sibly lead to an increased incidence of bac­
terial septicemia without a concomitant de­
crease in the incidence of fungal septicemia. 
Further clinical studies are necessary. In 
the meantime, after a patient has been 
receiving hypertonic glucose-amino acid 
through a central vein for 1 month, when 
essential fatty acids may become deficient,7 
we suggest that the 10% soybean oil emul­
sion be administered to provide essential 
fatty acids twice or thrice weekly through a
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peripheral vein, so that the central line re­
quired for long-term purposes is not vio­
lated and a central catherer may not be 
contaminated. Whenever 10% soybean oil 
emulsion is used as a caloric source, we 
recommend that this non-irritating emulsion 
be given in a peripheral vein via a steel 
needle that may be changed frequently.7' 18
C onclusions
In either 10% soybean oil emulsion or 
5% fibrin hydrolysate at 4°C, certain bac­
teria and C. albicans showed no growth. In 
10% soybean emulsion at 25 and 37°C, 
these organisms multiplied; in fibrin hydro­
lysate at these temperatures, C. albicans 
multiplied but the bacteria essentially did 
not.
Because fungal and bacterial sepsis (par­
ticularly fungal) is known to be a complica­
tion of the administration of hydrolysate- 
dextrose solutions, it may be more likely to 
occur with 10% soybean emulsion in which 
C. albicans and bacteria both multiply. 
Thus, when 10% soybean oil emulsion is 
given as a caloric source through an in­
dwelling central catheter, contamination of 
the emulsion or interruption in its flow could 
lead to an increased incidence of bacterial 
septicemia without a concomitant decrease 
in incidence of fungal septicemia. When 
possible, 10% soybean oil emulsion should 
be infused through a peripheral vein.
We wish to thank Dr. Lawrence Mautner, di­
rector of laboratories, and the department of 
microbiology of St. Joseph’s Hospital for their 
assistance.
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ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA OF THE LUNG 
SIMULATING CARCINOMA: PSEUDOLYMPHOMA WITH 
INFLAMMATORY CHANGES
G. H. C. JOYNT, MD, FRCS[C], FACS* and D. PANTALONY, MD, FRCP[C]t
Summary: Angiofollicular lymph node hyper­
plasia of the lung developed in a 45-year-old man 
who was a heavy smoker. Slow growth of the 
lesion 3 years after biopsy and the finding of 
atypical cells in the sputum and bronchial wash­
ings strongly suggested a malignant lesion. 
There were no systemic manifestations other 
than dyspnea, which may have been related to 
allergy. The lesion was angiofollicular lymph 
node hyperplasia of the hyaline-vascular type. 
Invasion by lymphoid cells of both blood vessels 
and bronchioles suggested that the pathogene­
sis was probably infectious or inflammatory; 
also, the nature of the infiltrate indicated an 
immune mechanism. The course of the disease, 
as in other cases reported, has been benign, 
though a patchy density has developed in con­
tralateral lung 4 years after lobectomy.
Resume: line hyperplasie des ganglions lym- 
phatiques angio-folliculaires du poumon s'est 
developpee chez un homme de 45 ans qui etait 
grand fumeur. La croissance lente de la tumeur 
3 ans apres la biopsie et la decouverte de cel­
lules atypiques dans les crachats et les lavages 
de secretions bronchiques constituaient une 
forte presomption de la presence d'une lesion 
maligne. Pas d'autres manifestation generate 
qu'une dyspnee, laquelle aurait pu etre attribute 
a une allergie. Au point de vue pathologique, la 
lesion etait une hyperplasie du ganglion angio- 
folliculaire du type hyalino-vasculaire. L'invasion 
de cellules lymphoi'des, tant dans les vaisseaux 
sanguins que dans les bronchioles permettait de 
croire a une pathogenie probablement infectieu- 
se ou inflammatoire et, d'apres la nature de 
I'infiltrat, semblait indiquer un mecanisme im- 
munitaire. Cette maladie, comme d'autres patho­
logies similaires deja rapportees, a eu une evolu­
tion benigne. On a cependant decouvert, dans 
le poumon contralateral, une zone de densite 
inegale, 4 ans apres la lobectomie.
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t Associate professor of pathology, University of 
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A ngiofollicular lymph node hyperplasia 
has numerous synonyms and, as a result, 
there is some confusion about its nature. Al­
though angiofollicular lymphoid hyperplasia 
has frequently been reported to have occur­
red in the mediastinum, neck, axilla, pelvis, 
retroperitoneal region and in the small bowel 
mesentery,1'3 its occurrence in the lung 
has rarely been reported.4, 3 The diagnosis 
is difficult to make.
The case reported in this paper illustrates 
some of the features of angiofollicular lymph 
node hyperplasia, and a critical review of 
the pathologic findings supports the theory 
that the pathogenesis is probably infectious 
or inflammatory rather than hamartoma- 
tous,4 (i with the possibility of an immune 
mechanism.
Case Report
A 45-year-old white man was admitted to 
hospital in July 1966 with a 3-month history 
of shortness of breath, with associated slight 
cough and scant mucoid sputum. He had 
smoked 20 cigarettes daily for 30 years. There 
was no history of hemoptysis or pain in the 
chest. The tuberculin test had been positive 
6 years previously. Sputum cultures and cy­
tologic examination of his sputum for malig­
nant cells were negative. A radiograph re­
vealed a lesion in the apical division of the 
left lower lobe (Fig. 1), and a left thoracotomy 
with wedge resection of the lesion was per­
formed. The pathologic diagnosis was organ­
izing pneumonia with lymphocytic infiltration 
(Fig. 2).
The patient remained free of symptoms. 
Radiographs were taken periodically, and one 
taken in February 1969 showed an increase in 
the density in the hilum of the left lung, at the 
site of the previous resection (Fig. 3). Further 
investigation revealed a normal blood count 
and occasional atypical cells and metaplastic 
changes in the sputum. A provisional diagnosis 
of carcinoma of the lung was made in Novem­
ber 1969 and the patient underwent broncho­
scopy and mediastinoscopy in December 1969; 
biopsy of the mediastinal node yielded no 
evidence of cancer. In January 1970 a further 
left thoracotomy with left lower lobectomy was 
performed.
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Fig. 1.—Chest radiograph (July 1966) show­
ing large shadow in left hilar area.
The circumscribed lesion contained in the 
left lower lobe measured 4 x 3.5 x 3 cm; the 
cut surface was tan and lobulated, with a few 
narrow projections of the tumour extending 
into the surrounding pulmonary parenchyma. 
Microscopically, the well-circumscribed lesion
Fig. 2.—Lymphoid cell infiltration of bron- 
chiolar mucosa and surrounding tissues (hema­
toxylin and eosin, reduced by 12% from x 280).
Fig. 3.—Chest radiograph (February 1969) 
showing increasing density of left hilar lesion.
extended to the pleural surface; a distinct 
nodular lymphocytic pattern was evident, as 
were numerous germinal centres. In many of 
the germinal centres there was a small blood 
vessel arching into the central areas (Fig. 4), 
together with hyalinization of vessels (Fig. 5).
Fig. 4.—Small vessel arching into germinal cen­
tre area. Note concentric lamellae of lymphocytes 
peripherally (hematoxylin-phloxine-saffron, reduced 
by 12% from x 1120).
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Fig. 6.—Lymphoid cells in intima of small ves­
sel apparently obstructing lumen (hematoxylin- 
phloxine-saffron, reduced by 12% from x 1120).
Fig. 5.—Germinal centre with sclerotic vessel 
and central hyaline deposits (hematoxylin-phloxine- 
saffron, reduced by 12% from x 1120).
Fig. 7 .—Focal lymphoid cell infiltration in and 
around bronchiolar mucosa. Note polypoid cell 
masses projecting into lumen (hematoxylin-phlo- 
xine-saffron, reduced by 12% from x 560).
The cellular composition o f the germinal cen­
tres was normal. In some interfollicular areas, 
cleftlike spaces were evident, and some spaces 
contained lymphocytes and lipophages. Also 
evident was lymphohistiocytic infiltration of 
some medium-sized and some small-sized 
blood vessels, chiefly in the intima (Fig. 6). 
Another striking finding was the focal collec­
tion o f lymphohistiocytic cells infiltrating the 
mucosa o f some bronchioles and peribronchial 
areas, similar to the benign lymphoepithelial 
lesion (Mikulicz’ disease) (Fig. 7). These lym­
phoid cell types, as well as scattered plasma 
cells, showed cytoplasmic pyroninophilia. 
There was no evidence o f asthma or other 
allergic diseases.
The patient remained well until 1972, when 
further investigations were carried out because 
o f attacks o f spasmodic dyspnea. The chest 
radiograph revealed no recurrence of the le­
sion and a left bronchogram showed no ab-
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normality. Radiographs of the nasal sinuses 
visualized mucosal thickening of the right 
maxillary antrum. Pulmonary function tests 
demonstrated a moderate degree of obstruc­
tion, which was not lessened appreciably 
after inhalation of a bronchodilator. This 
spasmodic dyspnea was attributed to allergy. 
Serum proteins were normal.
In January 1974, rheumatoid arthritis neces­
sitated a further admission. Radiography 
showed linear streaking at the right hilum. 
One year later a chest radiograph disclosed a 
patchy density at the right hilum, suggesting 
a recurrence of the original disease from the 
left lower lobe.
D iscussion
The names angiofollicular lymph node 
hyperplasia and angiofollicular lymphoid 
harmartoma underscore the controversy con­
cerning the nature of this lesion. Keller, 
Hochholzer and Castleman7 thought that 
the lesion is a hyperplasia, and provided 
evidence that certain features of the hyper­
plasia are those associated with certain in­
fections or inflammations. On the other 
hand, Lattes and Pachter3 and Tung 
and McCormack8 provided arguments 
favouring the hamartomatous and, in some 
cases, choristomatous nature of the lesion. 
Fisher, Sieracki and Goldenberg,9 in a de­
tailed analysis of one of their two cases, 
stated that the neoplastic nature of the le­
sion should be given much more serious 
consideration; the finding that a tissue mince 
of one of their cases not only grew in ham­
ster cheek pouches, but also metastasized, 
suggested that the lesion had, at least, 
malignant potential. However, all authors 
who have investigated and reported cases 
have shown that surgical resection is virtual­
ly curative, even in cases in which residual 
tissue was left; nor have any authors re­
ported evidence of metastases. Moreover, 
the lesions in those patients who have been 
followed up for long periods have grown 
slowly. In our patient there was some growth 
after 3 years.
Lesions have been reported to occur in 
many different sites. In the most recent ex­
tensive review, Keller, Hochholzer, and 
Castleman7 analyzed 81 cases and found 
that 70 of the lesions were in the mediasti­
num; 2 of the others were documented as
being intrapulmonary. Tung and McCor­
mack8 reported 5 cases, and reviewed a 
further 57. They recorded sites of the 62 
lesions as follows: of the 45 intrathoracic 
lesions 37 were in the mediastinum, and 8 
were embedded in lung tissue; and of the 
17 that were extrathoracic 6 were in the 
neck, 6 in the muscles, 2 in the pelvis, 2 
in the retroperitoneal space, and 1 in the 
axilla. The larger lesions tended to occur 
in the abdomen.
The original biopsy in our patient re­
vealed only inflammation and fibrosis (or­
ganizing pneumonia). A striking feature was 
the invasion of blood vessels, most notably 
the intima of medium-sized vessels. In one 
section, the collection of lymphoid cells 
apparently obstructed the lumen completely. 
This was more obvious in the lobectomy 
specimen and may have been responsible 
for the hyalinization of more distal small 
vessels. Both the large and the small blood 
vessels were free of any evidence of such 
invasion.
Similar lymphoid cells had invaded and 
disrupted some bronchioles, which was 
peculiar in that the invasiveness tended to 
be both focal and diffuse in the mucosa. 
These large lymphohistiocytic cells spilled 
over in some instances to the peribronchiolar 
tissues as well. This could be interpreted as 
showing active inflammation.
The resemblance of this lesion to that of 
Mikulicz’ disease of salivary glands is strik­
ing and may be a clue to an immune me­
chanism in the pathogenesis. Further evi­
dence for an immune mechanism is the 
cytoplasmic pyroninophilia of many of these 
cells; indeed, some of the larger cells re­
semble “immunoblasts” (reticular lympho­
blasts). The subsequent development of 
rheumatoid arthritis is noteworthy.
The areas of lymphohistiocytic infiltra­
tion and the areas of vascular and bronchial 
invasion were most evident adjacent to nor­
mal lung. Perhaps this represents the slowly 
advancing edge of the lesion. These findings 
are more in keeping with an inflammatory 
than a hamartomatous process.
Keller, Hochholzer, and Castleman7 
grouped these tumours into plasma-cell and 
hyaline-vascular variants. The plasma-cell 
varieties, though constituting no more than
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10 to 20% of their cases, were associated 
with systemic manifestations such as fever, 
anemia, hyperglobulinemia and thrombocy­
topenia. None of these, however, were evi­
dent in our patient. Our patient noted al­
lergic symptoms 2 years after lobectomy. 
He had predominantly the hyaline-vascular 
type of lesion, and this is in keeping with 
the lack of significant findings clinically, 
at the time of lobectomy.
The distinctive bronchial and vascular 
invasion of lymphoid cells was not com­
mented on in the one case of Tung and 
McCormack8 in which the lesion was in 
the right upper lobe of the lung; similarly, 
Keller, Hochholzer and Castleman7 made 
no mention of vascular or bronchial inva­
sion in the cases they described. However, 
Block, Morales and Allen10 did mention 
subendothelial lymphocytic infiltration in 
their case report.
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GLOMUS TUMOUR OF THE FINGERS*
JACQUES DUMONT, MD, FRCS[C]t
Summary; Clinical and therapeutic aspects of 
glomus tumour of the fingers have been con­
sidered by analyzing the records of 15 patients 
with glomus tumours. The tumour was found 
in the pulp in 5 patients and in the subungual 
region in 10. The diagnosis may be difficult to 
make and patients are often believed to be 
malingering. Complete surgical excision under 
magnification is curative.
Resume: 15 observations de tumeurs glomiques 
des doigts ont ete revues. La tumeur se trouva 
dans la face palmaire du bout du doigt de 5 ma- 
lades et dans la region sous-ungueale de 10. Le 
diagnostic peut etre difficile a faire et souvent 
les patients passent pour etre des simulateurs. 
Une excision chirurgicale complete faite sous 
grossissement conduit a la guerison.
gion of a finger. He recognized that the 
clear, round or polyhedral cells in this tu­
mour were similar to those found in the 
coccygeal gland (glomus coccygeum), and 
named the lesion a glomus tumour. Gross­
ly, the tumdur is soft, pink or purple, well 
defined and less than 2 mm in diameter. 
Microscopically, the tumour is highly dif­
ferentiated and is formed by an excessive 
proliferation of the glomus cells from the 
lumen of the Sucquet-Hoyer arterial canal 
(Fig. 2).
Clinical and therapeutic aspects of glo­
mus tumours have been considered by an­
alyzing the records of 15 patients with glo­
mus tumours.
A
*4
*
V f
G lom us tumour, considered by patholo­
gists1’ 2 to be a hamartoma rather than a 
true tumour, represents hypertrophy of 
the various elements of the normal glomus 
body (Fig. 1). The commonest location for 
ncuromyoarterial glomus is beneath the 
nail bed, followed by the volar surface of 
the fingertip. Wood,3 in 1812, gave the 
first accurate clinical account of these tu­
mours and described them as being “pain­
ful subcutaneous tubercles”.
The normal glomus is an arteriovenous 
anastomosis functioning without an inter­
posed capillary bed. The glomus body joins 
a cutaneous artery to a cutaneous vein with­
out the capillary bed, the Sucquet-Hoyer4 
canals giving direct communication between 
the arterial and the venous circulation. The 
glomus cells and a rich collection of nerve 
endings facilitate excellent control of blood 
flow by vasodilatation or vasoconstriction. 
This provides a mechanism for local regu­
lation of the total body temperature without 
dissipation of too much heat.
The pathologic anatomy of glomus tu­
mour was first described by Masson;5'8 the 
lesion was removed from the subungual re-
* Presented at the annual meeting of the Canadian 
Orthopaedic Association, St. John’s, Nfld., June 
25, 1974.
tDepartment of surgery, L’Hotel-Dieu de Quebec, 
11, Cote du Palais, Quebec, PQ G1R 2J6.
Patients  a nd  F indings
The series of 15 patients with glomus 
tumours comprises 7 seen at the Jefferson 
University Hospital, Philadelphia from 1966 
to 1972 and 8 at the Royal Victoria Hos­
pital, Montreal from 1958 to 1973.
Clinical Features
Clinical details are summarized in Ta­
ble I. The patients included 12 females and 
3 males, whose ages ranged from 10 to 70 
years. In 5 the tumours were localized to
/
PRIMARY 
COLLECTING V
A
(Sucquet -Hoyef canal)
A + V
Fig. 1.—Normal glomus body. Note direct arte­
riovenous communication by way of Sucquet- 
Hoyer canal.
A
A *
A
*> *
v
V
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TABLE I.—Clinical Details and R esults of Surgical T reatment for 15 P atients with Glomus
Tumour of the F ingers
Sex
Age
(y r )
Duration  
of sym ptom s Side Location R esults
F 59 M an y  years L T h u m b , subungual R ecurrence; cu red  b y  
second o p era tio n
F 35 2 yr L L ong finger, p u lp C ured
F 60 Since childhood L Index , subungual C ured
M 50 4 y r; failed  surgery L Index , subungual C tu ed
F 50 5 yr L R ing , subungual C ured
F 10 6 mo L L ittle  finger, subungual C ured
F 70 50 yr L L ittle  finger, p u lp C ured
M 33 3 yr L L ittle  finger, p u lp C ured
F 59 5 mo R T h u m b , sub u n g u al C ured
F 25 4 mo L R ing  finger, p u lp C ured
F 27 U nknow n L L ong finger, p u lp C ured
F 59 4 yr R R ing  finger, subungual C ured
M 23 Painless; biopsy R T h u m b , subungual C ured
F 21 U nknow n L In d ex  finger, subungual C ured
F 33 U nknow n L R ing  finger, subungual C u red
the pulp of the fingertip and in 10 they 
were subungual (Fig. 3). The clinical mani­
festations varied, most patients complained 
of lancinating pain, local tenderness and 
temperature sensitivity. In one patient the 
mass was clinically palpable in the pulp of
Fig. 2.—Microscopic features of glomus tumour. 
Note glomus tumour cells lining arterial canal, 
(hematoxylin and eosin, reduced by 38% from 
x 400).
the finger and bone erosion of the dorsal 
aspect of the distal phalanx of the finger 
was evident radiographically (Fig. 4). In 
three patients slight discolouration at the 
base of the nail bed was highly suspicious 
of the tumour. In all patients the exquisite 
pain could be reproduced by direct pencil- 
tip pressure applied over the lesion.
Treatment and Follow-Up
Surgical excision of the tumour was 
curative in all 15 patients. At the time of 
the retrospective review, 14 patients were 
asymptomatic. One patient had a recur­
rence, which was treated successfully by 
re-excision of the tumour.
In four of our patients a previous surgical 
procedure had been unsuccessful. One of 
these patients was an oral surgeon who had 
given up practice for approximately 6 
months because of disability; after re-ex­
cision the pain disappeared and he returned 
to work almost immediately.
Fig. 3.—Distribution of 15 glomus tumours: 10 
subungual and 5 pulp.
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Co m m e n t
These unusual lesions of the fingers often 
are not palpable, not visible and not detect­
able radiographically. The correct diagnosis 
will be made only by a careful history and 
examination of the patient.
Fig. 5.—Glomus tumour in pulp of fingertip. 
Tumour, in 70-year-old woman, had been present 
for 50 years; she had complained of pain at base 
of nail bed, and erosion of dorsal aspect of distal 
phalanx was apparent radiologically.
Carroll and Berman9 reviewed 28 cases 
of glomus tumour in the hand. Of the 28 
tumours, 14 were subungual, 11 were in 
the lateral aspect of the distal phalanx, and 
3 were localized more proximally in the 
palm of the hand. Carroll and Berman con­
cluded, as have others, that the diagnosis is 
difficult to make if the physicians are un­
aware of the condition; indeed, many pa­
tients with glomus tumours are believed to 
be malingering.
The lesion should be excised completely. 
Magnification facilitates this, and for this 
purpose a binocular loupe (x 2) is sufficient 
to visualize the lesion well. The procedure 
should be performed on an exsanguinated 
limb, with careful dissection at the site of 
maximal tenderness. Lesions in the pulp 
are generally readily visualized (Fig. 5). In 
the subungual region, the base of the nail 
should be resected, the germinal layer of 
the nail bed being protected; the tumour 
can then be excised.
I thank Dr. James Hunter of Philadelphia and 
the staff surgeons of the Royal Victoria Hospital, 
Montreal for allowing me to review their cases.
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THE FARFAN BACK OPERATION: TECHNIQUE AND RESULTS
DAVID B. FORBES, MD, FRCSfC]*
Summary: A total of 94 Farfan back operations 
were performed on 82 patients. As a group 
these patients were typical of those under­
going discoidectomy, with or without fusion. The 
follow-up period was from 3 to 5 years. Overall, 
the results were excellent, good or satisfactory 
in 85% of the patients; with one-level fusions 
the proportion of such results was 93%. The 
commonest cause of failure was extrusion of 
the bone graft.
Resume: Nous avons pratique 94 operations de 
Farfan sur la colonne vertebraie chez 82 ma- 
lades. Consideres en tant que groupe, ces 
malades appartenaient au type habituel devant 
subir la resection d'un disque intervertebral, 
avec ou sans fusion. Nous avons suivi ces ma­
lades pendant une periode variant de 3 a 5 ans. 
Dans I'ensemble, nos resultats ont ete excel- 
lents, bons ou satisfaisants chez 85% des mala­
des. La proportion de ces resultats est montee 
a 93% quand il s'agissait d’une arthrodese a un 
niveau. La cause d'echec la plus frequente a 
ete le rejet de la greffe osseuse.
The Farfan bone-block facet operation, first 
described by Dr. H. F. Farfan at a meeting 
of the Little Orthopaedic Club in Montreal 
in October 1968, was developed as a con­
sequence of research into the nature and 
effect of torsional stresses on the lower lum­
bar spine.1'4 It was shown that rotational 
stresses cause defects in the anulus fibrosus 
and that nuclear material is then extruded. 
The operation attempts to eliminate this 
movement at the affected joint by means of 
fusing the posterior facet joints. The joints, 
after suitable preparation, are forced apart 
by a solid block of bone, which has the 
effect of restoring or maintaining the dia­
meter of the spinal canal. Internal fixation 
is not used. In these ways, the operation 
differs from previously described facet fu­
sions advocated by Boucher5 and others.6
This paper is a report of the experience 
and results of 94 consecutive Farfan back 
fusion operations, all performed by the- 
author.
*Suite 320, 5300 Cote des Neiges, Montreal, PQ 
H3T 1Y3.
Patients and M ethods
Clinical Details and Results of
Investigations
In all, 82 patients (age range, 23 to 56 
years) had initial operations and 12 had 
two operations. Two patients had had a 
previous discoidectomy without fusion; these 
were considered as initial (fusion) opera­
tions. The minimum period of follow-up 
was 18 months and the maximum, 5 years 
(average, 3 years).
The average duration of symptoms was 
27 months (range, <  6 to >  12 months). 
All patients had a history of back pain of 
variable severity: it was mild in 29, mod­
erate in 46 and severe in 7 patients. Sciatic 
pain was a complaint (either mild or mod­
erate) in 56 of the 82 patients: the other 
26 had no sciatic pain. All had lost time 
from work; the time lost was measured in 
weeks or months in 55 instances. In all 
patients endurance was judged to have dim­
inished as indicated by their inability to 
play sports, need for frequent periods of 
rest, or curtailment of social activities; the 
diminution was slight in 23, moderate in 51 
and great in 8. All patients except 2 had 
taken some medication, the amount being 
described as “little” by 62 and “moderate” 
by 18. Preoperative treatment included a 
cast or brace in 55 patients and physiother­
apy in 69.
Physical examination revealed expected 
abnormalities as listed in Table I. A def­
inite neurologic deficit was found in 41 
patients, and 68 patients showed significant 
diminution of straight leg raising on the 
involved side, with 45 manifesting a differ­
ence in straight leg raising of more than 
20°.
Plain radiographs were obtained in all 
patients. Plain radiographs helped to rule 
out conditions that might mimic disc pro­
trusion and to select the proper level or 
levels for fusion. It was recognized early 
on that evidence of a failure of complete 
segmentation at L5-S1 justified a one-level 
fusion at the L4-5 level and that it was not 
necessary to fuse vertebrae at two levels 
in such cases. A large transverse process of
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L5 usually indicated stability at this level, 
as did partial lumbarization or partial sa­
cralization of the last segment. Also, disc 
narrowing at the L5-S1 level was regarded 
as indicating stability; thus, it was not nec­
essary to fuse the L5-S1 level under these 
circumstances. A high-riding vertebra at the 
L5-S1 level usually indicated instability at 
this level; in these cases the L4-5 joint did 
not require fusion. Flexion-extension films 
and fluoroscopy in motion also aided in 
proper selection of the level for fusion.
Myelography was carried out in 80 pa­
tients; it provided confirmatory evidence of 
disc protrusion. False-negative myelograms 
were noted in six patients (five at the L5-S1 
level). False-positive myelograms were de­
tected at operation in three patients. In the 
latter, the disc was left undisturbed. Discs 
that appeared normal were not incised. 
Myelography was not performed in patients 
in whom there was a possibility of allergy 
to the contrast medium or who were unduly 
anxious about the procedure.
Indications for Fusion
The indications for this type of spinal 
fusion are the same as those for other types 
of spinal fusion in the same area. The oper­
ation is done primarily for the relief of pain 
in a psychologically stable individual who
TABLE I.—Preoperative Physical F indings in 
82 Patients
Finding No. of patients
Back
Stiffness
Mild..................................... 31
Moderate............................  47
Severe.................................. 4
Tenderness
Mild..................................... 24
Moderate............................  54
Severe.................................. 4
Straight leg raising, affected 
limb*
0 to 30°............................ 24
31 to 50°...........................  8
51 to 70°............................ 36
71 to 90°............................ 26
Neurologic deficit
Motor..................................  18
Sensory................................  23
Reflex..................................  19
Combined...........................  9
*Total of 94, the number of operations performed.
is unable to carry on a reasonable level of 
physical (and psychologic) activity for a 
reasonably long period of time. The more 
acute the pain, the more significant the 
restriction of activities and the less effective 
the conservative treatment, the sooner the 
operation was performed. Less severe pain 
and more effective conservative treatment 
delayed operation.
Plain radiographic and myelographic 
evidence of disc disease were used as con­
firmatory evidence only. The decision to 
operate was made on clinical assessment re­
peated at intervals and on an evaluation 
of the patient’s psychologic status as re­
vealed during these repeated examinations.* 
Some patients, on psychologic grounds, did 
not seem to be ideal candidates for rehabili­
tation, but had such severe pain that the 
increased risk of a poor result was accepted 
because the chances of a good result ap­
peared to warrant the attempt.
Operative Procedure
The patient is placed in a modified knee- 
chest position. Through a posterior midline 
incision, the spinous processes and laminae 
are exposed subperiosteally (Fig. 1). Dissec­
tion is carried laterally beyond the facet 
joints. The capsule is removed from the pos­
terior and inferior aspects of the facet joints, 
but the anterior capsule is left intact to help 
limit the degree of forward placement of the 
bone graft. Articular cartilage and subchon­
dral bone are then removed from the facet 
joints, which creates a slot or pocket into 
which the graft is driven. A portion of a 
spinous process (Fig. 2) is removed (Fig. 3) 
and shaped to fit the slot, and the wedge- 
shaped graft is driven securely into the slot 
(Fig. 4).
Posterior extrusion of the graft is pre­
vented by a buttress of undenuded bone.
The same procedure is carried out on the 
other joint at the same level. Finally, the 
fusion is tested for stability. The original 
side is checked after both grafts have been 
inserted.
In all patients the fusion was thought to 
be clinically stable at the time of operation 
and no other means of grafting were used.
^Though not used in the current series, the Min­
nesota Multiphasic Personality Inventory is now 
often included.
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Supplementary grafting techniques were 
used only in failed cases. There were five 
cases not included in this series in which 
supplementary grafting was done at the 
time of the first operation.
Fig. 2.—Portion of spinous process to be re­
moved.
Certain points make for a successful 
fusion:
1. Stability. If instant stability cannot be 
obtained, the facet block fusion should be 
supplemented by other methods, such as an 
H-graft from the iliac crest.
2. Incision of capsule. The capsule is in­
cised in the direction of its fibres and then 
dissected back interiorly and superiorly to 
expose the joint. The anterior and superior 
portions of the capsule are left intact to help 
contain the graft.
3. Preparation of the joint. The postero- 
inferior portion (2 or 3 mm) of the medial 
facet is removed first. This improves the 
exposure of the joint. Then, the slot is 
designed to have parallel or, better, slightly 
concave sides. The latter shape, together 
with capsular preservation, helps prevent 
the posterior ejection of the graft; with a 
V-shaped trench with its base opening pos­
teriorly, the graft can be displaced posterior­
ly too readily. The slot is cleared of loose 
chondral fragments with a dental pick. Some 
roughness on the walls of the slot is de­
sirable.
Occasionally, a proper slot cannot be 
formed because of unusually shaped joints, 
technical errors or fresh laminar fractures. 
Instant stability is then not possible, and the 
facet fusion must be supplemented by an­
other type of fusion.*
*Results of this type of operation are not con­
sidered in this report.
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4. The graft. The sides of the graft 
should be roughened; the graft may be placed between the prepared surfaces either sideways or end on; the graft is impacted firmly into position using a bone punch, firmness being tested with a pick or forceps 
and by attempted rotation of the vertebra; and, if the graft is not solidly in place, the fusion is revised or supplemented.
Fig. 4b
Fig. 4.—Insertion of bone-block graft. Denuded joint surfaces are held apart by graft, (a) inferior aspect, (b) posterior aspect.
5. Suction drainage. Because raw bone is exposed, closed suction drainage is always used.
Rehabilitation
The patient is allowed out of bed 3 or 4 days after operation; initial ambulation avoids torsion, flexion and extension. Sitting 
is not allowed for several weeks; an exten­sion for the toilet seat is recommended. 
Usually no cast or brace is worn. The pa­
tient is discharged home independently am­
bulatory and able to take care of himself.
Postoperative Assessment
Results are classified as excellent, good, 
satisfactory and poor, according to the fol­lowing criteria:
1. Excellent: The patient has no pain in 
the back or the legs and is able to perform all usual activities, including contact sports. 
There is no neurologic deficit of conse­
quence. The back is supple and straight leg raising is full. The patient returns to work within 6 months.
2. Good: The patient has intermittent episodes of mild back or leg pain that does 
not seriously interfere with his or her life 
style. Endurance may be slightly diminished, 
but there is no appreciable neurologic defi­
cit. Analgesics are required occasionally. 
Full-time employment is resumed within 8 months of operation.
3. Satisfactory: There are occasional at­tacks of back or leg pain that, from time 
to time, necessitate periods of rest, analge­
sia and conservative treatment. Slight stiff­
ness and tenderness in the low back is no­ticeable. Full work is resumed within 1 
year of operation, but occasionally some days off are required.
4. Poor: Pain is rather more severe or 
continuous in the back or leg, and is punc­
tuated by periods of acute pain. Pain inter­
feres with normal activities. Prolonged con­
servative treatment is necessary. Bracing is 
common. Reoperation is often necessary.
R e s u l t s
Overall
The overall results are summarized in Table II. An excellent, good or satisfactory result was obtained in 85% of the patients.
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TABLE II.—Overall Results for 82 Patients TABLE IV.—Results after Second Operations
Result
No. of patients 
(and %) Result
No. of patients 
(and %)
Excellent........................ ..........  38 (46) Excellent........................ ..........  2 (17)
Good................................ ..........  26 (32) Good............................... ..........  5 (42)
Satisfactory.................... ..........  6 (7) Satisfactory.................... ..........  3 (25)
Poor................................. ..........  12 (15) Poor................................ ..........  2 (17)
Two-Level Fusion
The results of two-level fusion with and 
without single discoidectomy are provided 
in Table III.
One-Level Fusion
The results of one-level fusion, both with 
and without discoidectomy and overall, are 
listed in Table III.
Second Operations
Of the 82 patients, 12 had a second 
operation; in many this upgraded the result. 
The results of second operations are sum­
marized in Table IV. Thus, after all treat­
ment, 2 of 82 patients were left with a poor 
result, and 80 with a satisfactory result or 
better.
Reasons for Failure of Surgical Treatment
The commonest cause of failure was pos­
terior extrusion of the graft, which occurred 
in 8 of the 12 patients. In two others, a 
pseudoarthrosis was found, and in two 
others, who had had a one-level fusion, 
the wrong level had apparently been fused, 
and a two-level fusion was required.
Discussion and Conclusion
Of the many different types of lumbar 
spinal fusion techniques, the posterior bone 
block fusion has had much to recommend it 
on a theoretical basis.1'4 First, it stabilizes 
the spine against rotational strains; this can
be demonstrated at operation and is effected 
when the graft incorporates. Second, with 
the facet joints wedged apart, the diameter 
of the spinal canal is maintained or in­
creased, and this overcomes spinal stenosis. 
Indeed, in patients needing a second opera­
tion the commonest cause of failure was an 
extruded graft, with consequent narrowing 
of the spinal canal. Third, only a small 
amount of dissection and time (20 minutes) 
is necessary to perform the fusion. This is 
minimally traumatic. Fourth, early post­
operative ambulation with or without brace 
or cast is permitted after operation.
These theoretical advantages seem to be 
borne out by the postoperative results in the 
patients in the present series. An overall 
success rate of 85% was noted; the success 
rate was improved after second operations. 
A higher success rate was noted after one- 
level fusions (93%). These results included 
those for 35 patients in whom no disc pro­
trusion was found at operation and where 
the disc was left alone. Most of the two- 
level fusions were performed in patients 
treated early in the series.
With respect to failure of operations, the 
commonest cause of failure was extrusion 
of the graft. This was replaced at the second 
operation to restore the diameter of the 
spinal canal and to re-establish stability. A 
supplementary bone graft was also used. 
There may have been other cases of failure 
of bony fusion but satisfactory results were
- A
A
V
A
A
A
TABLE III.—R esults of T wo-Level and One-Level Fusions
Level of fusion and no. (and %) of patients 
Two-level One-level
Discoid- No discoi- Discoid- No discoi-
ectomy dectomy eciomy dectomy Overall
Result (n =  25) (n = 27) (n =  22) (n = 8) (n — 30) *
Excellent..................................... 13 (52) 8 (30) 13 (57) 4 (50) 17 (56)
Good............................................ 7 (28) 10 (37) 6 (29) 3 (38) 9 (30)
Satisfactory................................  2 (8) 2 (7) 2 (9) 0 ( 0 )  2 (7)
Poor............................................. 3 (12) 7 (26) 1 (5) 1 (12) 2 (7)
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obtained. It was not possible to determine 
with certainty in all patients whether a fu­
sion occurred. No attempt was made in this 
series to obtain serial postoperative radio­
graphs extending over a period of years in 
order to determine whether or not the fusion 
was solid.
Where lumbar fusion is indicated, the 
Farfan bone-block facet operation appears 
to have features more desirable than those 
of other fusions at present in use.
My sincere thanks to Dr. H. F. Farfan for 
his help with this paper, and to Mrs. L. Bastien 
for the preparation of the manuscript.
References
1. Farfan HF, Sullivan JD: Relation o f facet
orientation to intervertebral disc failure. 
Can J Surg 10: 179, 1961
2. Farfan HF: Effects o f  torsion on interverte­
bral joints. Can J Surg 12: 336, 1969
3. Farfan HF, Cossette JW, R obertson GH,
et al: Effects of torsion on lumbar inter­
vertebral joints: role o f  torsion in produc­
tion o f disc degeneration. J Bone Joint 
Surg [Am] 52: 468, 1970
4. Farfan HF: Mechanical Disorders o f  Low
Back, Philadelphia, Lea & Febiger, 1974
5. Boucher HH : Method o f spinal fusion. J Bone
Joint Surg [Br] 41: 248, 1959
6. Hibbs RA: Operation for  progressive spinal
deformities. NY State M ed J 93: 1013, 
1911
GLIMPSES OF SURGICAL HISTORY: F FOR FORCEPS
D. A. E. SHEPHARD
F o r c e p s  are so much an accepted part of 
the surgeon’s armamentarium that one for­
gets that they are at least 5000 years old. In 
design, forceps stem directly from the pre­
hensile structure of finger and thumb, which 
early man must have used to remove for­
eign bodies such as splinters. With man’s 
mastery over metal came the earliest forceps, 
used for religious and toilet purposes, so 
lamp tongs and epilation tweezers, both 
used as early as 3000 BC, seem to have 
been the antecedents of modern surgical 
and anatomical forceps.
The first surgical forceps were designed 
in Egypt circa 3300 to 2890 BC. The design 
of their forceps suggests that they were not 
used for epilation (though the Egyptian 
priests, for example, did practise total 
epilation “ in order that neither a louse nor 
any unclean thing shall settle on them when 
they are ministering to the Gods” , and eye 
diseases required removal of eyelashes); 
rather, they were strong enough to remove 
missiles and to hold skin during operations: 
the Ebers Papyrus refers to operations for 
which forceps were needed— herniotomy 
and repair of aneurysm, for example. Egyp­
tian forceps are important because Roman 
and later European forceps evolved from 
them. Comparison of modern surgical and 
anatomical forceps with those of Egypt and
Rome is fascinating; surprisingly little has 
changed in design.
But in other respects, particularly forceps 
for hemostasis, much has changed. For cen­
turies bleeding in wounds was inadequately 
staunched by means of stinging styptics and 
searing cautery. Then Ambroise Pare (1510- 
1590) was brave and eccentric enough to 
use a bullet-grasping instrument, shaped 
like a raven’s beak (bee de corbin), to hold 
a bleeding artery for ligation. Thus began 
the influence of instrument makers on 
surgery, for the armourer’s bullet-extraction 
forceps, derived from tooth-extraction for­
ceps, were the origin of Pare’s artery for­
ceps.
Instrument makers, however, did not ap­
preciably influence the art of surgery until 
the early 19th century; before, surgeons 
had used tools forged by smiths, armourers 
and cutlers. But after about 1830 instru­
ments were designed for surgical use by 
surgical instrument makers, and the crafts­
manship of men such as Charriere in France 
led surgeons to owe much to the ingenuity 
of these men. Yet even these fine artificers 
were the descendants in art of Egyptian and 
Roman craftsmen, so that today surgeons 
may look on their work with admiration 
and reflect that their professional forbears 
must have expressed the same debt to in­
strument makers then as they do today.
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ELECTROMYOGRAPHIC AND NERVE CONDUCTION STUDIES IN 
IDIOPATHIC ISCHEMIC NECROSIS OF THE FEMORAL HEAD
G R. VIVIANI, MD, FRCS[C],* M. E. BRANDSTATER, MD. MB, BS, MRCP, 
FRCP[C], PhDt and E. G. BEATTY, MD, BSc, FRCPatht
Summary: Clinical features and results of nerve 
conduction and electromyographic investigations 
were studied in 13 consecutive patients with 
idiopathic ischemic necrosis of the femoral 
head. Of these patients, one was a diabetic, 
one had received steroids and six gave a his­
tory of high alcohol intake. Neurologic abnor­
malities were present in 9 of the 13 cases. 
Specimens were available for examination in 
the nine patients who underwent operation. This 
study suggests that disturbance in the neuro­
muscular system at a clinical or subclinical 
level could be common to idiopathic ischemic 
necrosis of the femoral head and its various as­
sociated disorders and might be a pathogenetic 
factor.
Resume: Chez 13 malades consecutifs souffrant 
d’une necrose ischemique de la tete femorale 
d’origine idiopathique, nous avons passe en re­
vue les caracteristiques cliniques et les resul- 
tats fournis par des etudes sur la conduction 
nerveuse et par des traces electromyographi- 
ques. De ces 13 malades, un etait diabetique, 
un avait recu des corticoi'des et six avaient des 
antecedents d’alcoolisme. Dans 9 des 13 cas, 
des anomalies neurologiques etaient presentes. 
Chez les neuf malades qui avaient subi une 
operation, on disposait d’echantillons pour fins 
d'examen. Le present travail permet de croire 
que le trouble du systeme neuromusculaire, tant 
au point de vue clinique qu’au niveau subclini- 
que, est couramment observe dans la pathologie 
en question et dans les divers troubles con- 
nexes et pourrait constituer un facteur patho- 
gene.
Idiopathic  ischemic necrosis of the femoral 
head has been observed with increasing fre­
quency in recent years. Zinn1 reported that 
this diagnosis was made in 2 to 3% of all
* Assistant professor of surgery, orthopedics, Mc- 
Master University Medical Centre, Hamilton, Ont.
tAssociate professor of medicine, Chedoke Hos­
pital, Hamilton.
tAssociate professor of pathology, Hamilton Gen­
eral Hospital.
Reprint requests to: Dr. G. R. Viviani, Depart­
ment of surgery, McMaster University Medical 
Centre, 1400 Main St. W., Hamilton, ON L8S 4J9.
cases of chronic hip disease at the medical 
clinic in Bad Ragaz, Switzerland. The clin­
ical, radiographic and pathologic features 
have been well defined by a number of 
workers.1'4
The clinical and pathologic features can 
be correlated with characteristic radiograph­
ic changes. In the asymptomatic early stages 
mottled areas of increased density (stage 1) 
or a demarcation of a dense area of 
infarction (stage 2) can be seen.3 Stage 3 
is associated with the onset of pain and is 
characterized radiographically by a peculiar 
crescent or subcortical radiolucency in the 
femoral head. Later there are progressive 
flattening and compression, and superim­
posed degeneration. The pathologic and ra­
diologic features of idiopathic ischemic 
necrosis of the femoral head are shown in 
Figs. 1 to 3.
Associated with idiopathic ischemic ne­
crosis of the femoral head is a high incid­
ence of various disorders, including alco­
holism, diabetes, gout, obesity, liver disease, 
hyperlipidemia, anemia and other blood dis­
orders, rheumatoid arthritis, systemic lupus 
erythematosus, renal disease and minor 
trauma. It has also been found associated 
with analgesic drugs5 and is often preceded 
by administration of drugs, especially 
steroids.6
Fig. 1.—Femoral head with concentric appear­
ance of visibly preserved cartilage. Note distinct 
lines of demarcation marking underlying collapse 
of subcortical bony tissue.
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Fig. 2.—Radiographs of coronal slabs of femoral head removed at operation. Clearly shown are 
loosening of subcortical bone (a), bone destruction and resorption (b), and sclerosis in remaining viable 
areas (c).
The purpose of this study was to evalu­
ate further the disorders frequently associ­
ated with ischemic necrosis of the femoral 
head and, specifically, to examine the hy­
pothesis that disturbance in the neuromus­
cular system is a factor common to most 
of these associated disorders.
Patients and Methods
Patients were referred to the authors for 
study by orthopedic surgeons in the Hamil­
ton region and were gathered by unselected 
and consecutive referral. A detailed history- 
included that of alcohol intake, of therapy 
with steroids and other drugs, and of pre­
vious trauma. The clinical review included 
orthopedic and neurologic assessment and 
laboratory investigations.
Fig. 3.—Tomographic demonstration of degree 
of anatomic change of femoral head. Note col­
lapse and flattening of weight-bearing area, with 
step in medial third of articular surface, and 
cyst-like defects and irregular densities replacing 
normal trabecular pattern. Joint space is well 
preserved despite severity of damage of femoral 
head.
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The accepted criteria for the diagnosis of 
idiopathic ischemic necrosis of the femoral 
head as described by Marcus, Enneking and 
Massam3 were met in 13 patients. The sex 
and age distribution is shown in Fig. 4. The 
diagnosis was confirmed in nine of the pa­
tients by pathologic examination of speci­
mens removed at surgery.
io| | MALE 
3 ^  FEMALE
Fig. 4.—Age and sex distribution of patients 
with idiopathic ischemic necrosis of femoral head.
Nerve Conduction Studies and
Electromyography
Nerve conduction and electromyography 
(EMG) were performed using the following 
procedures: motor nerve conduction of the 
median nerve, ulnar and peroneal nerves; 
sensory nerve conduction of the medial, 
ulnar and sural nerves; motor unit counts 
in the hypothenar, thenar and extensor digi- 
torum brevis muscles,7 and needle EMG.
R esults
Associated Disorders
The conditions associated with idiopathic 
ischemic necrosis of the femoral head in­
cluded a high alcohol intake (usually over 
1344 ml [4 bottles] beer or 340 ml liquor 
daily) in 6 patients, and diabetes in 1; 
steroid therapy was recorded for 1; and no
TABLE I.—N eurological D iagnoses in
P atients with Idiopathic Ischemic Necrosis 
of F emoral H ead
Neurologic disease No. of patients
Polyneuropathy.................... 7
Alcohol........................... 3
Diabetes......................... 1
Unknown....................... 3
Lumbar root lesions............. 2
Normal.................................. 4
Total..................................... 13
disorder could be identified in the other 5 
of the 13 patients. The neurologic findings 
are summarized in Tables I and II. In 9 of 
the 13 patients there was definite clinical 
or neurophysiologic evidence of underlying 
neuromuscular impairment.
Nerve Conduction and Electromyography
Abnormal features detected by nerve con­
duction and EMG examination were slow­
ing of motor and sensory nerve conduction, 
low-amplitude sensory nerve action poten­
tials, reduction in numbers of residual 
functioning motor units and evidence of 
denervation on needle EMG study. The 
EMG data (Table III), though not complete 
for some of the patients examined early in 
the series, were adequate for interpretation 
and diagnosis. In two patients the EMG 
evidence alone was equivocal, but the clin­
ical features definitely established the diag­
nosis of polyneuropathy.
Comment
The clinical and pathologic features of 
idiopathic ischemic necrosis of the femoral 
head noted in these patients conformed to 
the descriptions given in the literature of 
this clearly defined entity. The pathologic 
changes observed are similar to those pro­
duced in experimental ischemia, and this 
has led to the hypothesis that the patho­
genesis is related to altered hemodynamics 
—for example, vascular occlusion from 
fat microembolism.8 The hemodynamic 
mechanism may be venous occlusion, as 
impaired venous drainage of the femoral 
head has been observed.9 Other authors 
have inclined to the view that microfractures 
occur, with poor healing subsequently at­
tributed to associated disorders or to medi­
cation that could obstruct protective pain 
mechanisms. 5>6
In this series of patients a high incidence 
of definite neurologic and EMG abnormali­
ties was observed. None of the patients 
manifested the clinical or pathologic charac­
teristics of a neuropathic joint as described 
by Horwitz.10
It is possible that the many conditions 
associated with idiopathic ischemic necrosis 
of the femoral head frequently have neuro­
logic abnormalities and that our findings
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TABLE II.—N eurologic and Electromyographic F indings
Patient
no.
Age
(yr) Sex
Clinical neurologic 
features EMG Neurologic diagnosis
i 28 M No positive findings Normal No neurologic abnormality
2 63 M No positive findings Slow nerve conduction, 
denervation
Polyneuropathy
3 67 M Sensory loss in legs Slow conduction velocities, 
reduced motor unit count, 
denervation
Polyneuropathy
4 69 M Diminished vibration 
in legs
Low motor unit counts, 
distal denervation
Polyneuropathy
5 46 M Numbness right hand Denervation in ulnar and 
lumbar root distri­
butions
Pressure neuropathy ulnar 
nerve, lumbar root lesion
6 66 F Distal sensory loss Slow nerve conduction, 
denervation
Polyneuropathy
7 75 M No definite positive 
findings
Low motor unit counts, de­
nervation, reduced sensory 
amplitudes
Polyneuropathy
8 73 F Pain, weakness and 
sensory loss both legs
Normal conduction velocity, 
denervation in legs
Multiple lumbar root lesions
9 49 M Weakness, sensory loss Slow conduction velocity, 
low motor unit counts, 
denervation
Polyneuropathy
10 62 M Sensory symptoms 
both hands
Slow conduction in median 
nerves, low motor unit 
counts
Bilateral carpal tunnel syn­
drome. Polyneuropathy
11 76 F No positive findings Moderate reduction in 
motor unit counts
Ageing
12 48 M No positive findings Normal No neurologic disease
13 63 M No positive findings Normal No neurologic disease
TABLE I I I . - -Electromyographic D ata
Patient no.
1
2
3
4
5
6
7
8 
9
10
11
12
13
Normal
Nerve conduction velocity
(m/s)
Motor Sensory
Motor unit count 
{no. of units with motor 
nerve stimulation)
U*
52
44 
51
53 
50 
56 
55
45 
53
49
59
49
M*
60
43
Nil
54 
60 
52
52
47
53 
43 
56
55
49
P*
39
34
44
46
51 
49 
43 
46
Nil
52
42 
46
43
U*
64
Nil
54 
56 
51
55 
59
Nil
63
47
53
49
M*
60
Nil
52
53 
59 
44 
62
50
51
52 
43 
56
53
49
p*
45
Nil
39
34
49
42
Nil
Nil
45
42 
37
43
Hyp*
320
142
320
380
340
250
Then* EDB*
280
240
45
120
245
270
220
140
109
78
14
Nil
85
64
150
110
120
*Abbreviations: U = ulnar nerve; M = median nerve; P = peroneal nerve; Hyp =  hypothenar muscle; 
Then = thenar muscle; EDB = extensor digitorum brevis muscle.
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represent a purely chance relationship. Al­
ternatively, the high incidence of neurologic 
abnormalities may reflect a common patho­
genetic factor. This could operate through 
neurogenic vascular dysfunction,11 through 
reduction in pain threshold, or impairment 
in the reflex mechanisms of muscle action 
that act to minimize stress on the bone.
The clinical and experimental evidence 
indicates that there are numerous possible 
causes of idiopathic ischemic necrosis of the 
femoral head. The observations in this study 
lead us to conclude that an abnormality in 
neural mechanisms is frequently present in 
this disorder, and that such may represent 
a common pathogenetic factor.
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PHOTOGRAPHIC MAPS FOR CORONARY ARTERY OPERATIONS: 
HOW TO MAKE THEM EASILY*
GERALD M. FITZGIBBON, LRCP&S(I) FRCP[C], FACP, FACCt
Summary: A modification of the Tagarno 35-mm 
cine-film projector has been devised primarily 
for the cardiac surgeon, to produce excellent 
pictures of opacified coronary arteries. A com­
bined screen and photographic holder allows the 
surgeon to view an image 10.2 x 12.7 cm and 
to make positive prints of selected frames in 
a matter of seconds. No photographic experi­
ence is needed.
Resume: line modification du cine projecteur 
35 mm Tagarno, pensee specialement pour le 
chirurgien qui se specialise en chirurgie cardio- 
vasculaire, pour produire d'excellentes images 
d'arteres coronariennes opacifiees, est ici de- 
crite. Un ecran combine avec un porte-papier 
photographique, permet de voir une image de 
10.2 x 12.7 cm, et sert aussi a imprimer tres 
rapidement des epreuves positives des images 
deja choisies. Aucune connaisance photographi­
que n’est necessaire.
Skilled  coronary artery surgery requires 
good selective coronary angiograms. These 
are obtained in several ways but none rec­
ords diagnostic morphologic detail, especial­
ly during tachycardia, as well as 35-mm 
cine-film exposed to synchronous pulsed ra­
diation at 60 frames per second or more. 
However, there is need for readily available 
representative pictures of opacified coronary 
arteries that do not require a special viewer 
for study because, unless he has a remark­
able memory or sufficient artistic talent to 
draw accurately what he sees on the pro­
jection screen, the surgeon requires a ref­
erence map during the operation. Small co­
ronary vessels, such as the lateral (diagonal) 
and some posterolateral (marginal) left ven­
tricular branches of the main divisions of 
the left coronary artery, may appear easily 
identifiable on the cine screen but may be 
difficult to identify when a specific vessel 
or vascular segment is sought.
*From the cardio pulmonary unit, National De­
fence Medical Centre, Ottawa, Ont.
tAssociate professor (cardiology), department of 
medicine, University of Ottawa.
Reprint requests to: Dr. G. M. FitzGibbon, 
Cardio-pulmonary unit, National Defence Medical 
Centre, Ottawa, ON K1A 0K6.
To fill this need, the screen and film 
holder* shown in Figs. 1 and 2 was devised 
to produce enlarged positive prints from 
individual frames selected during study of a 
cine-coronary angiographic record on a 
Tagarno 35-mm projector. Designed initial­
ly to hold photographic paper, the device 
was soon modified as a viewing screen 
holder (Paterson “par speed” intensifying 
screen cut to fit) of convenient size (ap­
proximately 10.2 x 12.7 cm) for examina­
tion by a limited number of persons; a blue 
filter in the optical train added esthetic 
value by dispelling the yellowish-white tinge 
of the usual image.
* Manufactured by Mr. Gerry Volz, 126 North­
western Ave., Ottawa, ON.
Fig- 1.—Tagarno projector with screen film 
holder in position. Holder can be put in place or 
removed in seconds; fits old and later model pro­
jectors.
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Fig. 3.—Coronary angiograms before (two left columns) and after (right column) emergency aorta- to-anterior descending coronary venous bypass. This 49-year-old man had crescendo angina with ventri­cular arrhythmia, unresponsive to treatment in intensive care unit; he did not have myocardial infarct and has done well. Original prints, after cropping, were 8.0 x 8.5 cm; when mounted, montage was photographed without touching-up or “dodging”, density and contrast being kept as close as possible to original. LCA =  left coronary artery; RCA =  right coronary artery; SVG =  saphenous vein graft; PA =  posteroanterior; RAO =  right anterior oblique; LAO =  left anterior oblique; L Lat =  left 
lateral; AD =  anterior descending branch of left coronary artery; SAN =  sinoatrial node artery; AVN =  atrioventricular node artery; unlabelled arrows indicate arterial stenosis in preoperative angio­gram; circles show site of arterial occlusion noted after operation.
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Prints are made as follows: Under sub­
dued incandescent light, Ilford CS2.1P 
glossy single-weight paper (10.2 x 12.7 cm) 
is placed in the screen holder; a timer short- 
circuits the Tagamo projector lamp switch 
and film negative is exposed to printing 
paper for approximately 10 to 50 seconds 
(judging exposure time and “dodging”* are 
talents that are easily acquired, and a hand­
held cardboard mask of appropriate size en­
sures a white-bordered positive print) and 
the exposed paper is run through an Ilford 
model 1502 rapid processor, using Ilfoprint 
1A-13 Activator and IS-12 Stabilizer, pro­
ducing slightly damp prints in 10 seconds. 
If these are to be kept indefinitely and ex­
posed to light and warmth, they must be
* Intermittently interrupting parts o f the light path 
from the projector lens to the paper by a card or 
paddle in order to achieve optimum contrast.
fixed within weeks; if required urgently they 
can be marked with a fine felt pen at once.
Fig. 3 demonstrates pictures made by this 
method. No photographic experience is nec­
essary; I had none and developed the tech­
nique by trial and error. My surgical col­
league (W. J. Keon, personal communica­
tions 1972 to 1975) is enthusiastic about 
the technique; the reference sets of an­
notated coronary artery pictures arriving in 
the operating room with my patients may 
have facilitated the fashioning of four to 
six distal coronary artery bypasses in 43% 
of them, because the “operating map” 
draws the surgeon’s attention to less obvious 
lesions in the smaller coronary arteries.
I thank Mr. David May of the Canadian Armed 
Forces Directorate of Documentation and Draw­
ing Services for annotating Fig. 1 and for drawing 
Fig. 2.
THE WARREN (DISTAL SPLENORENAL) SHUNT 
FOR PORTAL HYPERTENSION*
R. M. STONE, MD, FRCS[C], P. WATERS, MD and B. LANGER, MD, FRCS[C], FACS
Summary: The Warren distal splenorenal shunt, 
designed to decompress esophagogastric varices 
selectively while preserving portal venous 
inflow to the liver, was performed in 18 patients 
who had bled from esophageal varices. In 14 cir­
rhosis was micronodular, in 3 it was macronodu- 
lar, and in 1 primary biliary. Two patients died 
within 1 month of surgery (operative mortality, 
11%). Three patients died between 2 and 12 
months after operation (1-year mortality, 28%). 
All five patients who died within 1 year had 
severe liver disease at the time of operation. 
None sustained further hemorrhage. Only one 
survivor requires protein restriction and none 
have fluid retention.
Resume: Le pontage splenorenal distal de War­
ren, congu pour decomprimer selectivement les 
varices oesophago-gastriques, tout en maintenant 
intact le retour du sang de la veine porte vers le 
foie, a ete pratique chez 18 malades qui avaient
*From the division of general surgery, Toronto, 
General Hospital, and the University of Toronto, 
Ont.
Reprints requests to: Dr. R. M. Stone, Room 108B, 
University wing, Toronto General Hospital, Toron­
to, ON M5G 1L7.
presente des hemorragies par varices oesopha- 
giennes. Chez 14 de ces malades, la cirrhose 
etait de la forme micronodulaire, chez 3 autres 
macronodulaire et chez le dernier, il s'agissait 
d'une cirrhose biliaire primitive. Deux malades 
sont morts dans un delai d’un mois apres Cope- 
ration (mortality operatoire: 11%). Trois autres 
malades sont morts entre 2 mois et 12 mois 
apres I'intervention (mortality d'un an: 28%). 
Les cinq malades qui sont decedes dans le de­
lai d'une annee souffraient tous d'une hepato- 
pathie severe au moment d’etre operes. Aucun 
des operes n’avait subi une nouvelle hemor- 
ragie. Parmi les survivants, il n’a fallu re- 
courir a la restriction proteique que dans un 
cas. Aucun des operes ne presentait de reten­
tion hydrique.
Several prospective studies1' 2 comparing 
surgical and medical treatment for patients 
with bleeding esophageal varices have failed 
to show any appreciable advantage of a sur­
gical approach. Among patients treated med­
ically, the mortality has been attributable 
largely to recurrent variceal hemorrhage, 
and among those treated by a shunt proce­
dure a similar mortality has resulted from
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progressive hepatic failure. The surgical 
procedures reported in these prospective 
studies have been shunts that totally deprive 
the liver of afferent portal blood flow; and 
whether a shunt is an end-to-side portacaval, 
a side-to-side portacaval, a mesocaval, or a 
classical splenorenal shunt, the effect on 
hepatic portal blood flow is essentially the 
same.
Fig. 1.—Umbilicoportogram showing portal and 
part of splenic veins and huge coronary vein. 
Note poor opacification of liver. (Two lines in­
dicate position of 12th rib.)
Fig. 2.—Umbilicoportogram showing portal and 
splenic veins with collaterals in area of short 
gastric vessels. Note good hepatic opacification 
indicating significant forward portal flow.
The volume of afferent hepatoportal blood 
flow in portal hypertension varies. In some 
patients by the time variceal hemorrhage 
occurs, there is a sufficient collateral blood 
flow such that portal venous inflow to the 
liver has decreased to zero (Fig. 1). In other 
patients, however, a large volume of portal 
blood continues to perfuse the liver (Fig. 2). 
We3 have studied the portal contribution 
to total hepatic blood flow in a series of 
patients with alcoholic liver disease, by 
means of a modification of a method using 
xenon-133.4 We found that in 6 patients 
with fatty liver but normal portal pressure 
the portal venous flow varied from 40 to 
80% of total hepatic blood flow, and that 
in 14 with established cirrhosis and portal 
venous pressure exceeding 16 mm Hg the 
portal venous flow ranged from zero to the 
normal (Fig. 3).
Warren and colleagues,5 using different 
techniques, made a similar observation; they 
postulated that an operatior that would, on 
the one hand, preserve afferent hepatoportal 
blood flow and at the same time decompress 
the esophagogastric plexus of veins might 
also obviate the relentless hepatic decom­
pensation that follows standard shunting 
procedures. Warren, Zeppa and Fomon6 
suggested that such an effect could be pro­
duced by devascularizing the lesser and 
greater curves of the stomach, except for 
the short gastric vessels, and implanting the 
splenic end of the divided splenic vein into 
the left renal vein (Fig. 4). This procedure, 
the distal splenorenal shunt, would allow 
superior mesenteric venous blood to con-
PORTAL PRESSURE
Fig. 3.—Portal vein blood flow (as percentage 
of total hepatic blood flow) in 6 patients with 
fatty liver but normal portal pressure and in 14 
patients with cirrhosis and portal hypertension.
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Fig- 4.—Features of Warren, distal splenorenal shunt. Note ligation of coronary vein and preser­vation of short gastric vessels.
tinue flowing into the liver and would en­
courage gastric blood to flow through the 
short gastric vessels into the spleen rather 
than through the variceal plexus at the up­
per end of the stomach and lower esophagus. 
Experience with this operation has been re­
ported by others;7 this communication is a 
report of the results of the distal spleno­
renal shunt in 18 patients.
P a t ie n t s  and M ethod
Clinical Details
Since August 1971, 18 patients have un­
dergone the distal splenorenal shunt at the 
Toronto General Hospital. Details of the 
type of cirrhosis and of Child’s classification 
of the disease in these 12 men and 6 women 
are given in Table I. No patient was oper­
ated on while actively bleeding, but all pa­
tients except one had bled within the month 
before operation. Preoperative assessment in 
all patients included biochemical tests of 
liver function, liver biopsy, barium examin­
ation of the upper gastrointestinal tract,
TABLE I.—T ype of Cirrhosis and Child’s Clas­
sification in 18 Patients Undergoing Warren Shunt
Item No. of patients
Type of cirrhosisMicronodular..................... 13Macronodular...............................  4Primary biliary.................. 1
Child’s classification (class)A .....................................................  4B .....................................................  6C .....................................................  8
esophagogastroduodenoscopy, hepatic and 
splenic arteriography, hepatic vein catheter­
ization with pressure measurements and 
venography, venocavagraphy, and left renal 
venography. In eight patients the umbilical 
vein was catheterized and total hepatic and 
portal blood flow was determined.
Operative Technique
We have modified the procedure of War­
ren, Zeppa and Fomon: 6 we make a long 
midline incision and approach the lower 
border of the pancreas through the gastro­
colic omentum rather than below the trans­
verse mesocolon. It has never been neces­
sary to abandon the operation for technical 
reasons, though the operating time is usually 
1 hour longer than the time needed for a 
portacaval shunt. The difficult part of the 
operation is dissection of the splenic vein. 
It is usually necessary to divide 6 to 12 
short, fine, pancreatic branches of the 
splenic vein just to the left of the inferior 
mesenteric vein to obtain an adequate length 
of 4 to 5 cm. Most of the operative bleeding 
occurs during this part of the dissection. It 
has not been necessary in this series to 
divide the renal vein, although this can be 
done if extra length is needed. Renal prob­
lems related to the operation, except in the 
case of the patient who died with the hepa­
torenal syndrome, have not been encoun­
tered.
The same surgical and anesthetic teams 
operated on all the patients.
R esu lts
The important results of the distal sple­
norenal shunt in the 18 patients are sum­
marized in Table II.
TABLE II.-—R esults of Warren Shunt in 18 Patients
Item No. of patients
For all 18 patients Mortality1 - month........................ 2 (11%)1 - year............................ 5 (28%)Rebleeding....................... 0
For 13 survivorsEncephalopathy................ 0Ascites................................. 0Dietary protein restriction 1Medication......................... 1
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Two patients died within 1 month of 
operation, one at 21 days and the other at 
30 days; the operative mortality thus was 
11%. Both patients who died had been 
categorized in Child’s class C at the time of 
operation. One patient was a 65-year-old 
man in whom pneumonia and progressive 
respiratory failure developed; the other was 
a 40-year-old man with the hepatorenal 
syndrome.
Three patients died between 2 and 12 
months after operation, so that there was 
a total of five deaths within 1 year of opera­
tion (1-year mortality, 28%). With respect 
to the three latter patients, the condition 
of two at the time of operation was Child’s 
class C and one was class B. The patient 
with class B disease died from acute hepatic 
failure after a prolonged bout of drinking; 
at autopsy acute severe alcoholic hepatitis 
was found superimposed on micronodular 
cirrhosis.
No patient in this group sustained further 
hemorrhage; this includes the five patients 
dying within the 1st year. Of the 13 sur­
vivors, none have encephalopathy or fluid 
retention; 10 are alcoholics as confirmed 
by history and liver biopsy, but only 2 have 
continued to drink since operation. All 
patients have been taking a “no-added salt” 
diet. The follow-up period is too short to 
permit comment on long-term survival.
D isc u ssio n
The standard operation for portal hyper­
tension, against which all others must be 
compared, is the end-to-side portacaval 
anastomosis; this is still the most frequent 
type of portosystemic shunt for portal hy­
pertension. The mortality and frequency of 
rebleeding for the present group of patients 
treated by the distal splenorenal shunt are 
comparable to that reported by others using 
the portacaval shunt.8 The incidence of 
encephalopathy appears to be less, though 
the series is as yet too small and the follow­
up period too short to substantiate this early 
observation. These patients are included in 
a prospective randomized trial comparing
the distal splenorenal and portacaval shunts. 
This trial should in time show how effective 
the distal splenorenal shunt is in decreasing 
the incidence of encephalopathy and late 
hepatic failure.
The continuing measurement of portal 
venous and hepatic arterial blood flow may 
help determine which patients are at risk 
from encephalopathy and allow one further 
discretion in selecting both patient and oper­
ation.
C o n c l u sio n s
Results of the Warren distal splenorenal 
shunt for portal hypertension in 18 patients 
indicate that the mortality is comparable 
to that of conventional shunts. The opera­
tion appears to prevent recurrent variceal 
hemorrhage and may be associated with a 
lower incidence of postoperative encephalo­
pathy or fluid retention, or both. Confirma­
tion of the validity of these preliminary ob­
servations must await completion of a ran­
domized prospective trial.
References
1. Jackson FC, Perrin EB, F elix WR, et al:
Clinical investigation of portacaval shunt. 
V. Survival analysis of therapeutic oper­
ation. Ann Surg 174: 672, 1971
2. Resnick RH, Chalmers TC, Ishihara AM,
et al: Controlled study of prophylactic 
portacaval shunt. Final report. Ann Intern 
M ed  70: 675, 1969
3. Stone RM, T enhove W, Effros R, et al:
Portal venous blood flow: its estimation 
and significance (abstract). Gastroentero­
logy 62: 186, 1972
4. Shizgal HM, Goldstein MS: Measurement
of portal and total hepatic blood flow by 
intestinal xenon technique. Surgery 72: 
83, 1972
5. Warren WD, F omon JJ, Viamonte M, et al:
Preoperative assessment of portal hyper­
tension. Ann Surg 165: 999, 1967
6. Warren WD, Zeppa R, F omon JJ: Selective
trans-splenic decompression of gastroeso­
phageal varices of distal splenorenal shunt. 
Ann Surg 166: 437, 1967
7. Reichle FA: Portal hemodynamics after distal
splenorenal (Warren) shunt. Ann Surg 176: 
195, 1972
8. H allenbeck GA, Wollaeger EE, Adson MA,
et al: Results after portal-systemic shunts 
in 120 patients with cirrhosis of liver. 
Surg Gynecol Obstet 116: 435, 1963
The Effect of
IVasy lol
in
Hyperfibrinolytic
Hemorrhages
Trasylol, in its role as an 
antifibrinolytic agent, inhibits 
both plasmin and the 
plasminogen activator.
Synthetic antifibrinoiytic 
agents inhibit only the 
plasminogen activator.
Trasylol is indicated for primary and generalized, secondary 
hyperfibrinolytic hemorrhages with and w ithout the shock 
syndrome. Secondary hyperfibrinolysis fo llow ing 
intravascular clotting may require heparin and/o r 
fibrinogen replacement in addition to Trasylol. 
With Trasylol, the antifib rino iytic agent with 
simultaneous anti-coagulant (anti-throm boplastic) 
effect, there will not be a dangerous shift 
in the equilibrium  between 
the clotting and the lysis system 
in favour of coagulation. 
Synthetic an tifib rino lytics 
are contra indicated if there is 
evidence of active intravascular 
coagulation. Trasylol is indicated 
in all cases of hyperfibrinolysis, 
whether a d ifferentia l diagnosis 
has been made or not.
FBA Pharmaceuticals Ltd.
D istributed by:
Boehringer Inge lhe im  (C anada) Ltd.
Fibrin
Fibrinogen
Factors V, VIII
Kininogens
Trasylol
synthetic 
inhibitors of 
fibrinolysis
Plasminogen
Activator
Plasmin
Trasylol
570 THE CANADIAN JOURNAL OF SURGERY Vol. i s
Trasylol
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Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P 1J3
IMPROVING OXYGEN DELIVERY OF 
BLOOD IN HEMORRHAGIC SHOCK
Since in stored blood the oxyhemoglobin 
dissociation curve shifts progressively left­
ward, it is likely that in a patient receiving 
stored blood a given oxygen consumption is 
maintained only through an increased car­
diac output or a decreased venous oxygen 
tension. In contrast, with blood having a 
normal or less than normal affinity for oxy­
gen, with a rightward dissociation shift, 
oxygen consumption should be maintained 
at a lower cardiac output. And since hemo­
globin affinity for oxygen is inversely related 
to erythrocyte organic phosphate concentra­
tion, tissue oxygenation should be improved 
at lower cardiac work through manipulation 
of erythrocyte oxygen transport by altera­
tions in blood phosphate concentrations.
C. L. Rice and colleagues (J Surg Res 
19: 193, 1975) used this argument in study­
ing the resuscitative effect in shock of trans­
fusing erythrocytes treated to have a de­
creased oxygen affinity and in determining 
whether such blood would restore oxygen 
consumption at a lower cardiac output.
Hemorrhagic shock was induced in 14 
baboons. Resuscitation was effected by 
transfusion of either 21-day-old homologous 
blood (in controls) or fresh autologous blood 
incubated with pyruvate, inosine, dextrose, 
adenine, sodium chloride and sodium phos­
phate (treatment group). The investigative 
emphasis was on the changes in values for
2.3- diphosphogly cerate (2,3-DPG) and 
50% -oxygen saturation of hemoglobin 
(P-,o) in relation to hemodynamic changes. 
Rice and colleagues found that (1) treated 
blood had higher 2,3-DPG and P50 values 
than did the stored blood, and (2) treated 
animals had a greater arteriovenous oxygen 
difference and lower cardiac work than did 
the control animals.
These findings indicate that P50 and
2.3- DPG values can be altered in vivo and 
that an elevation in these values can improve 
the physiologic response to blood replace­
ment in hemorrhagic shock. Various un­
certainties of concept and technique remain 
to be clarified, but thereafter it should be 
possible to exploit more fully the manipula­
tion of the erythrocyte oxygen dissociation 
curve in patient care.
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DEVELOPMENT AND EVALUATION OF USE OF CHOLECYSTOKININ 
IN THE DIAGNOSIS OF ACALCULOUS GALLBLADDER DISEASE*
WILLIAM N. COHEN, MD and JOEL B. FREEMAN, MD, FRCS[C]
Summary: The need to differentiate patients 
with acalculous gallbladder disease who would 
benefit from cholecystectomy and those who 
would not led to the search for a procedure 
that would be of value in this respect. For this 
purpose, cholecystokinin (CCK) has been used, 
and many reports have indicated that CCK does 
identify patients in whom the gallbladder is the 
source of pain. A review of papers dealing with 
CCK as a diagnostic aid suggests, however, that 
some radiographic evaluations have not been 
subjected to adequate, unbiased interpretation 
and that some follow-up studies have been in­
complete and of short duration. Despite these 
objections there is evidence that CCK can be 
useful as a diagnostic aid, and further, con­
tinued, well-designed studies are indicated.
Resume: C'est la necessity de differencier les 
malades souffrant de cholecystopathies non cal- 
culeuses et qui pourraient beneficier d'une cho- 
lecystectomie de ceux qui n'en retireraient pas 
le meme profit qui a incite les chercheurs a 
trouver une methode susceptible d’etre fruc- 
tueuse dans ce domaine. Nous avons, a cet 
egard, utilise la cholecystokinine (CCK). De 
nombreux rapports ont indique que la CCK 
permet reellement d'identifier les malades dont 
la vesicule biliaire est a I'origine de la douleur. 
Toutefois, en passant en revue les articles trai- 
tant de I'emploi de la CCK comme moyen diag- 
nostique, on a constate que certaines evalua­
tions radiographiques n'ont pas ete soumises a 
une interpretation adequate et impartiale et que 
certaines observations catamnestiques ont ete 
incompletes et de trop courte duree. Malgre 
ces objections, on possede des preuves que la 
CCK est un outil diagnostique utile et on estime 
qu’il faudrait continuer a I'employer en le sou- 
mettant a de nouvelles etudes approfondies.
Until the early part of this century, the 
clinical diagnosis of gallbladder disease was 
made predominantly by means of the history 
and clinical examination. However, in the 
19th century two ancillary tests had been 
advocated. One consisted of collecting the
*From the departments of radiology and surgery, 
University of Iowa College of Medicine, Iowa 
City, IA.
Reprint requests to: Dr. J. B. Freeman, Depart­
ment of surgery, University of Iowa Hospitals 
and Clinics, Iowa City, IA 52242, USA.
feces of a patient who had experienced an 
attack of possible “biliary colic” and pass­
ing the feces through a sieve, even daily for 
months, to retrieve the dislodged gallstone. 
The other was described by Whittaker, who, 
in 1882, introduced a needle percutaneously 
into a palpable gallbladder and felt the 
grating sensation of the needle tip against 
a large calculus; this diagnosis was verified 
at cholecystostomy, but the patient did not 
survive.
U se of Duodenal D rainage
In the early 20th century Meltzer de­
scribed the choleretic effect of magnesium 
sulfate instilled directly into the duodenum. 
Lyon1 applied this principle clinically by 
intubating the duodenum and instilling 50 
to 100 ml of 25% magnesium sulfate 
through the tube. As the bile began to 
flow, three fractions were observed: the 
first, “A” bile, comprised 10 to 20 ml of 
translucent, light-green bile that had passed 
from the common bile duct; the second, 
“B” bile, came from the gallbladder itself 
and was signalled by an abrupt transition 
to flow of 30 to 100 ml of a darker bile; 
and the third, “C” bile, was translucent and 
originated in the hepatic ducts. In patients 
with cholecystitis the bile so obtained was 
turbid and contained mucus and bacteria; 
in cholelithiasis it was gritty and contained 
bile salt or cholesterol crystals. The magne­
sium sulfate was presumed to have a direct 
relaxing effect on the sphincter and induced 
gallbladder contraction by the “contrary 
innervation” thesis. Although this mechan­
ism was questioned and the value of the 
test disputed,2 the test did become popular 
as a relatively simple and accurate means 
for supplementing the findings of the his­
tory and physical examination in the diag­
nosis of gallbladder disease. The use of 
this test diminished after the development 
of cholecystography but its advantages have 
been advocated by authorities such as 
Bockus,8 and as recently as 1973 a report 
documented its value in the diagnosis of 
acalculous cholecystitis and cholesterolosis.4
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L imitation of Oral 
Cholecystography
The oral cholecystogram is highly ac­
curate in the diagnosis of calculous gall­
bladder disease (an accuracy exceeding 
95% when the gallbladder is opacified); it 
is, however, of limited value in diagnosing 
symptomatic acalculous conditions. Al­
though the presence of cholesterolosis and 
adenomyomatosis of the gallbladder can be 
detected, the clinical correlation is not 
necessarily clear. These conditions as well as 
"euromuscular disorders and narrowing of 
tne cystic duct are only indirectly and with 
variable reliability suggested by a poor re­
sponse to a fatty meal or persistent opaci­
fication after 24 hours.5
TABLE I.—Reported Results of Cholecystec­
tomy of Acalculous Gallbladders
Proportion of 
unsatisfactory
Author results, %
Whipple (1926).............................. 23Muller (1927)................................. 24Graham and Mackey (1934). . . 60*Lehman (1936)..............................  36Glenn and Mannix (1956).......... 36f
•Partial relief was obtained in 50% of patients. (Partial relief was obtained in 33% of patients.
The results of removal of acalculous gall­
bladders reported by several surgeons 
are indicated in Table I. It is apparent that 
cholecystectomy failed to relieve pain in an 
average of approximately one-third of pa­
tients with such lesions. These experiences 
prompted Warren H. Cole to write in 1938, 
“one-third to one-half of cholecystectomies 
performed throughout the country are in 
patients without gallstones . . .  a large per­
centage of failure due to erroneous diag­
nosis . . .  others, cystic duct lesions and 
biliary dyskinesia”.6 There is, therefore, a 
need to differentiate those patients with 
acalculous disease who would benefit from 
cholecystectomy and those who would not, 
presumably because their pain originates 
elsewhere than in the biliary tract.
Introduction of Cholecystokinin
In 1928 Ivy and Oldberg7 described a 
hormone that induced gallbladder contrac­
tion and evacuation. It was an extract from
the upper intestinal mucosa and was distin­
guishable from secretin. It had no vasodila- 
tory effect. Its humoral action was verified 
by cross-circulation experiments in which 
acid injected into the duodenum of one dog 
triggered the release of a material that 
caused the gallbladder in the other to con­
tract. In addition to hydrochloric acid but­
ter, digested egg yolk and cream with olive 
oil also induced gallbladder contraction after 
being instilled into the duodenum. Two 
years later Ivy, Drewyer and Orndoff8 per­
formed the first cholecystokinin (CCK) 
cholangiogram. After the gallbladders of 
eight human subjects had been opacified 
with tetraiodophenolphthalein, 20 to 30 mg 
of a partially purified CCK extract was in­
jected. At least partial gallbladder evacua­
tion was achieved in six of the eight indi­
viduals; however, two felt “light headed” 
and one had an urticarial reaction. These 
workers concluded that the diagnostic value 
was doubtful since the resulting contraction 
was no better than that achieved after the 
ingestion of egg yolk. However, in 1947 
Ivy9 proposed for the first time that CCK 
might be of value in the diagnosis of biliary 
dyskinesia.
Although Denton, Gershbein and Ivy10 
later showed that injection of an improved 
extract of CCK produced evacuation in five 
of eight human subjects, it was not until 
Jorpes and M utt11 obtained a highly puri­
fied CCK that this technique was widely 
used in man. Use of as little as 3 mg would 
predictably cause the gallbladder to con­
tract, with maximum contraction 10 to 20 
minutes after the intravenous infusion. 
They advocated its clinical use predomin­
antly to replace egg yolk as an evacuant 
after cholecystography. In their laboratory 
they produced CCK in sufficient quantity 
to make it commercially available in 
Sweden.
Additional physiologic studies were per­
formed by Torsoli and associates12 with 
dose and rate effects being defined. A 30- 
minute intravenous infusion of 75 U of CCK 
produced a slow, even evacuation of the 
gallbladder that approximated the physio­
logic emptying from an egg-yolk meal, but 
when the injection was accomplished in 30 
seconds the gallbladder contracted in a 
hyperactive and spasmodic fashion. A 3-
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TABLE I I —Summary of Results of Cholecystokinin Injection* and of Cholecystectomy R e­
ported in Studies of N athan and Colleagues16' 17
Proportion o f subjects show ing  
effect, %
C ontrols
Variable
P a tien ts  
(n  =  141)
M D s
(n  =  35)
N o n -M D s  
(« = 107)
Symptoms
“RUQ pain, epigastric pain, or cramps” ................ 57 26 5
Radiographic abnormality
“Gallbladder, cystic duct spasm” ............................ 92 6 3
Postcholecystectomy benefit
Complete relief or great improvement..................... 94 f — —
*75 U in 15 to 30 s.
fNumber of patients undergoing cholecystectomy, 70.
minute injection produced an even contrac­
tion of the gallbladder, approximately 40% 
of the gallbladder contents emptying by 20 
minutes in healthy persons.
Evaluation of Use of
Cholecystokinin
The refinement of CCK led to additional 
efforts in its use in the diagnosis of noncal- 
culous disorders of the gallbladder. These 
disorders include the cystic duct syndrome 
(partial obstruction), ampullary stenosis, 
clinical cholesterolosis, biliary sludge for­
mation and biliary dyskinesia. Small series 
have been reported in which CCK in con­
junction with oral cholecystography was 
helpful in selecting patients who would bene­
fit from cholecystectomy.1315 Relatively 
larger or cumulative experiences by Nathan 
and associates,16’ 17 Goldstein and asso­
ciates,18'20 Nora, McCarthy and Sanez,5 
Dunn and colleagues21 and Freeman, Cohen 
and DenBesten22 will be reviewed.
Studies by Nathan and Colleagues
The largest cumulative series was re­
ported by Nathan and associates in 196916 
and subsequently added to in 1970.17 The 
total series comprised 141 patients and 142 
controls. The patients had a history sugges­
tive of gallbladder disease in conjunction 
with normal oral cholecystograms; 70 un­
derwent ‘ cholecystectomy. The controls, 
some of whom were physicians, were 
asymptomatic and entirely composed of 
men between the ages of 21 and 35 years. 
The exclusion of Indians, Mexicans and 
women was thought to provide a group of
controls who were at lowest risk for latent 
gallbladder disease.
Cholecystokinin was given as an intra­
venous injection of 75 U in 15 to 30 
seconds. The variables evaluated were re­
production of the symptoms and radio- 
graphic alterations. The symptoms were de­
fined as right upper quadrant or epigastric 
pain or cramps. The radiographic criteria 
consisted of gallbladder or cystic duct spasm 
or both; the rate and degree of emptying 
of the gallbladder were excluded as valid 
criteria. The results of these studies are 
summarized in Table II. There was a signi­
ficant difference in the reproduction of gall­
bladder symptoms between the nonphysi­
cian controls (incidence of symptoms, 5% ) 
and the patients (57%). There was, how­
ever an incidence of “gallbladder symp­
toms” among physician controls of 26% , 
which was attributed to their suggestibility 
and insight into the action of CCK. Hyper­
peristalsis and diffuse abdominal cramping 
to a variable degree is a frequent side effect 
of CCK.
Nathan and his colleagues observed a 
striking difference between the radiograph­
ically abnormal results in the patient group 
and those in the control group, with no 
significant difference in results between the 
physicians and the nonphysicians. These 
authors did not state whether the cholecys- 
tographic sequences were evaluated without 
prior knowledge of the patient’s history or 
the symptom complex that followed the in­
jection of CCK. The authors did note that 
spasmodic contractions can occur soon after 
a 30-second intravenous injection of
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TABLE III .—Summary of Results of Cholecystokinin Injection* and Surgical and Medical 
Treatment, in Study of Goldstein and Associates20
C a teg o ry  o f  d iso rd er
V a r ia b le
C y s tic  du ct 
syn d ro m e  
(n  =  28 )
S p h in c ter
d istu rb a n ce
(n  =  8)
G allb ladder  
h yp erco n tra c t ion  
(n  =  6 )
C on tro ls  
(:n =  J7)t
Pain reproduction Symptomatic pain in all Biliary type in all Biliary type in all No biliary 
type pain
Degree of gallbladder 
emptying
Vol. decrease of 0-50% Poor, of gallbladder 
contrast visualized 
to sphincter
80% in 5 min 50-80% in 
5-15 min
Relief from
cholecystectomy
Satisfactory in 
15 (25 operated, 
17 followed)
Satisfactory in all 
3 (fibrous stenosis)
Satisfactory in 
all 5
Relief from medical 
treatment
— Satisfactory in all 
5 (anticholinergics)
Satisfactory in 
1 patient
*60-90 U in 3 min. 
■(■Reported in prior study.19
75 U of CCK in normal subjects but they 
regarded this as abnormal when persisting 
beyond 4 minutes. Among 66 patients 
whose symptoms were completely relieved 
or greatly improved after cholecystectomy, 
94% were followed up from 3 to 48 
months. Among the others, the condition of 
3 of the 70 patients was not improved and 
that of 1 was only slightly improved. Ex­
amination of the gallbladders removed 
from these patients revealed predominantly 
chronic cholecystitis, with occasional cho- 
lesterolosis and superimposed acute cho- 
cholecystitis.
Study of Goldstein and Associates
The findings reported by Goldstein and 
associates1'" relating to 17 controls and 42 
patients are summarized in Table III. Their 
basic technique differed from that of Nathan 
and colleagues in that CCK was injected 
more slowly, over 3 minutes. Their radio- 
graphic evaluation relied heavily upon the 
change in gallbladder volume, which was 
calculated according to the method of Sif- 
fert and Silva.23 They grouped their patients 
into those having the cystic duct syndrome,* 
those with disturbance of the sphincter of 
Oddi and those with hypercontraction of the
*An additional six patients, not formally included 
in their study, had pain and CCK cholecysto- 
graphic findings identical to the patients included 
in their study, but these six at operation were 
found to have tiny calculi acting as ball valves 
embedded in the cystic duct.
gallbladder attributed to cholesterolosis. In 
all instances CCK precipitated a symptoma­
tic gallbladder type of pain and the gall­
bladder volume did not decrease at the nor­
mal rate. The surgical results indicated sa­
tisfactory relief of symptoms in 23 out of 
25 patients in whom follow-up observations 
were recorded (period of follow-up, 6 
months to 11 years). Although the cholecys- 
tographic assessment was not made in a 
blind fashion, the calculation of volume 
provided a more objective evaluation than 
the spasmodic patterns described by Nathan 
and his group.
Study of Nora, McCarthy and Sanez
Nora, McCarthy and Sanez5 obtained 
cholangiograms after 75 U CCK had been 
injected over 3 minutes. Abnormal re­
sponses included duplication of symptoms, 
abnormal contraction, prolonged visualiza­
tion, and a decrease in volume of less than 
50% by 20 minutes. Among the 19 patients 
examined, the results were abnormal in 10. 
Cholecystectomy relieved the symptoms of 
all patients in this group. Cholecystectomy 
also relieved symptoms in those patients 
operated upon on the basis of prolonged 
retention (at least 24 hours) of radiographic 
contrast in the gallbladder; 3 g of iopanoic 
acid (Telepaque) had been used.
Study of Dunn and Associates
The results of a well-controlled study 
were reported by Dunn and associates,21 
who obtained cholecystograms after the in-
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TABLE IV.—Summary of R esults of Cholecystokinin Injection* and of Surgical and M edical 
T reatment,! in Study of Du nn  and Associates21
Proportion o f subjects 
showing effect, %
Patients
Variable
Symptoms o f 
biliary colic 
(n = 49)
Symptoms of 
dyspepsia 
(n =  25)
Controls 
(n = 44)
“Gallbladder-like pain or discomfort” ......................... 65 44 27
Radiographic abnormality!
“Criteria described by previous authors17- 18......... 31 43 28
*75 U in 45 s.
fCured or improved, independent of CCK results; 80% of the 29 patients undergoing cholecystectomy; 60% 
of 40 patients without operation, 
tAverage 3 radiologists, higher observer disagreement.
jection of 75 U of CCK over 45 seconds. 
The cholecystograms were interpreted inde­
pendently by three radiologists who had no 
knowledge of either the subjects’ clinical 
histories or of their symptomatic responses 
to CCK. The radiographs were evaluated by 
the criteria of Cozzolino and associates18 
(percentage decrease in gallbladder volume 
after a 2-minute injection of CCK) and of 
Nathan and colleagues17 (previously de­
scribed). Both the 74 patients and the 44 
controls were predominantly women; the 
control subjects were paramedical volun­
teers such as nurses and technicians without 
symptoms of gallbladder disease.
Dunn and associates found a modest sep­
aration in the provocation of gallbladder 
symptoms between the controls and the clin­
ical groups (Table IV), but no significant 
difference in the radiographic responses be­
tween the two groups (there was, however, 
a high observer disagreement [28% ] in the 
interpretation of the radiographs). Follow­
up examinations revealed that 80% of the 29 
patients who were operated on reported im­
provement after cholecystectomy; however, 
60% of those who were not operated on 
also noted spontaneous alleviation of their 
symptoms. These authors concluded that, 
because their study was well controlled with 
blind interpretation of the films, the results 
carried greater validity than those of earlier 
studies. They therefore stated that “cho­
lecystokinin cholecystography, as currently 
performed, is of little or no value in the 
diagnosis and management of patients with 
possible acalculous biliary tract disease . .. 
another possible explanation of the discrep­
ancy . . .  is that we do not know how to
differentiate a normal from an abnormal 
gallbladder roentgenographic response to 
cholecystokinin.”
Despite the careful and meticulous prep­
aration of the protocol of the study of Dunn 
and associates, some questions can be raised 
about their procedure. The rapid (45-sec- 
ond) rate of injection may produce a spas­
modic contraction of the gallbladder in nor­
mal subjects and create a false-positive in­
terpretation of the examination. This was 
noted by Nathan and his group, whose 
criterion was a factor in their interpretation; 
but it is not clear that the three radiologists 
in Dunn’s group distinguished between early 
normal spasmodic contractions and late ab­
normal contractions. They also quoted as 
the basis for their interpretation the work 
of Cozzolino and associates,18 who injected 
CCK over 2 minutes and noted the change 
in gallbladder volume, which was negated as 
significant by Nathan and his group, to be 
the predominant criteria for abnormality. 
These two methods are therefore in conflict 
with one another and it is difficult to under­
stand how the methodologic differences can 
be reconciled. The higher observer disagree­
ment in interpretation might have been a 
result of the confusion generated by this in­
herent conflict. On the other hand, if the 
volume change itself were the basis for 
interpretation of normal versus abnormal 
such a measurement could be calculated ob­
jectively, with little room for observer varia­
tion. Perhaps the second possibility raised 
by these authors—that they may not have 
known how to interpret the radiographic 
results—should not be dismissed. With re­
spect to the narrowed differential between
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the clinical and control groups in subjective 
response, it was argued that their control 
group, by being composed of paramedical 
personnel, was exposed to the suggestibility 
that Nathan and his group observed with 
physician controls. Also, being composed 
predominantly of women the control group 
contained individuals at higher risk for gall­
bladder disease, and the possibility of some 
latent abnormality could have been present.
Study by Freeman, Cohen and DenBesten
Freeman, Cohen and DenBesten22 per­
formed a series of 31 examinations in which 
an analysis of the “B” bile (gallbladder) 
drainage was combined with cholecysto- 
graphic findings and evaluation of clinical 
response. These authors infused 75 U of 
CCK in 3 minutes, but the radiographs were 
interpreted with the knowledge of the pa­
tient’s response. With this three-pronged ap­
proach 22 examinations were considered 
abnormal on the basis of three broad classi­
fications (Table V); 9 were negative. The 
first of these three classifications consisted 
of a hyperkinetic neuromuscular response 
to CCK in which the reproduction of symp­
toms was predominant. The gallbladder 
showed hyperactive aberrations in the form 
of changing shape and spasmodic contrac­
tions about the neck. This group contained 
10 patients, 5 of whom had partial obstruc­
tions of the cystic duct, 1 a stenosis of the 
ampulla of Vater, and the remaining 4 a
dyskinetic neuromuscular response without 
an organic obstruction. In the seven patients 
constituting the second there was a hypo­
kinetic neuromuscular response: the pain 
response was minimal but gallbladder emp­
tying amounted to less than 50% by 30 
minutes. The five patients in the third group 
responded normally with respect to radio- 
graphic appearances and manifested no 
clear symptomatic response to CCK. How­
ever, analysis of the “B” bile showed that 
it contained crystals of cholesterol and cal­
cium bilirubinate, in one instance it grew 
Escherichia coli with Clostridia. The duo­
denal drainage therefore identified some 
patients who would not have been detected 
otherwise.
All of these 22 patients noted improve­
ment after cholecystectomy, although 1 re­
quired a second operation for a missed 
ampullary stenosis. This corresponded well 
with the predicted result if one assumes that 
the one-third of the total group (the nine 
patients with negative test results) would 
not have benefited from surgical treatment. 
However, this assumption is based on the 
overall experience of others.
Since the original report an additional 
40 patients have been selected for surgical 
treatment with similar rewarding results. 
However, the analysis of biliary lipids as 
mentioned in the original publication has 
not been helpful and therefore has been 
discontinued.
TABLE V.—Summary of E ffects of Cholecystokinin Injection* and Cholecystectomy, in Study
of F reeman, Cohen and D enBesten22
Category of response
Variable
Hyperkinetic 
(n = 10)
Hypokinetic 
0n = 7)
Normal
(n =  5)
Pain response Reproducing symptoms 
predominate
Minimal; symptoms not 
reproduced
None
Radiographic features Active “fighting” gallbladder 
with rounding of contour 
and/or spasm of neck; ten­
dency to delayed emptying
Flaccid gallbladder, weak 
contractions; less than 
50% emptying by 30 min
Normal
Bile analysis Crystals of 
cholesterol and 
calcium biliru­
binate; E. coli 
and Clostridia in 1
Relief from 
cholecystectomy!
Complete in 8; 
improvement in 2
Satisfactory in all Satisfactory in all
*75 U in 3 min.
(Includes 1 sphincteroplasty.
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Conclusions
Because cholecystectomy is of no benefit 
in approximately one-third of those patients 
with epigastric and right upper quadrant 
pain, a normal cholecystogram and no other 
identifiable cause of pain— presumably 
because the pain originates elsewhere— a 
means of selecting those who will benefit is 
necessary. The use of CCK has been pro­
posed to augment cholecystography or bili­
ary drainage procedures, or both, to identify 
those patients in whom the gallbladder is 
indeed the source of pain, and most reports 
indicate that the use of CCK does achieve 
this end. The criticism of Dunn and col­
leagues that the previously reported studies 
using CCK cholecystograms have not been 
subjected to adequate, unbiased interpreta­
tion is valid. In addition, some of the fol­
low-up studies have been incomplete and 
conducted over a short period. Nevertheless, 
there is evidence that CCK can be useful 
in fulfilling this diagnostic need. Therefore, 
continued studies with better control to 
evaluate specific elements of technique and 
parameters of interpretation are warranted.
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ANORECTAL AND PERIANAL COMPLICATIONS OF HEMATOLOGIC 
MALIGNANT NEOPLASMS*
M. BAKRI MUSA, MD, MSc, FRCS[C], SURESH B. KATAKKAR, MB, BSt and 
ABDUL KHALIQ, MB, FRCP[C]
Summary: Among 17 adults with hematologic 
malignant neoplasms in whom anorectal com­
plications developed, the overall mortality was 
53% ; for those in whom the disease was not 
in remission the mortality was 69%, compared 
with zero for patients who were in remission. 
All but one of the deaths were directly attri­
butable to septicemia secondary to the anorec­
tal lesion. Over half of the patients had a his­
tory of previous anorectal problems or disor­
dered bowel pattern preceding the anorectal 
complication. The anorectal lesions affecting 
these 17 patients included prolapsed hemor­
rhoids (in 5); discrete ulcers in the anal canal 
and surrounding cellulitis (8); necrosis of the 
anus and perianal area (2); and perirectal ab­
scesses (2). Only the abscesses responded to 
surgical drainage. Treatment of the other le­
sions was conservative: bowel function was 
maintained as normal as possible, good perineal 
hygiene was practised and stool softeners were 
used, while efforts were directed towards 
achieving remission of the hematologic neo­
plastic disease.
Resume: Chez 17 adultes souffrant de neopla- 
sies hematologiques qui avaient presente des 
complications anorectales, la mortalite globale 
a ete de 53%. A noter le fait que la mortalite 
etaient de 69% chez les malades dont la patho- 
logie n'etait pas en periode de remission, alors 
qu'elle etait nulle chez les malades en remis­
sion. Tous les deces, sauf un, ont ete directe- 
ment attribuables a une septicemie secondaire 
a la lesion anorectale. Plus que la moitie des 
malades avaient des antecedents de troubles de 
la region anorectale ou des troubles intestinaux, 
avant I'apparition des complications anorectales. 
Les lesions anorectales dont souffraient les 17 
malades etaient composees d’hemorroi'des pro- 
cidentes (5 cas), d’ulceres discrets du canal 
anal et de cellulite adjacente (8 cas), de necrose 
de I’anus et de la region peri-anale (2 cas) et 
d ’abces de la region perirectale (2 cas). Seuls, 
les abces ont reagi au drainage chirurgical. Le
*From the Dr. W. W. Cross Cancer Institute, Ed­
monton, Alta.
tFellow in clinical oncology, University of A l­
berta, Edmonton.
Reprint requests to: Dr. M. Bakri Musa, Dr. 
W. W. Cross Cancer Institute, 11560 University 
Ave., Edmonton, AB T6G 1Z2.
traitement des autres lesions a ete conserva- 
teur. On s’est efforce de maintenir la fonction 
intestinale aussi normal que possible, de prati- 
quer une bonne hygiene perineale et d'utiliser 
des produits ramolissant les selles, tout en fai- 
sant ('impossible pour realiser une remission de 
la neoplasie hematologique.
A lt h o u g h  the presumed pathogenesis and 
suggested management of such benign 
anorectal conditions as hemorrhoids, fis­
sures and fistulous abscesses are well de­
scribed in surgical texts, similar anorectal 
complications in patients with malignant 
neoplasms of blood-forming tissues (leu­
kemia, lymphoma and myeloma) are not 
widely discussed in the surgical literature. 
Such conditions are, however, familiar to 
medical oncologists, and it is our impression 
that these anorectal lesions are, in most in­
stances, sufficiently different from those in 
the general population that they must be 
treated differently. We also believe that sur­
gery has a limited role in the management 
of the anorectal problem in these patients.
This paper is a review of our experience 
with this problem at the W. W. Cross Can­
cer Institute, Edmonton, which admits pa­
tients with cancer primarily for radiation 
therapy and for chemotherapy.
Pa t ie n t s  a n d  M e t h o d s
From 1969 to 1974, 17 patients were 
found to have anorectal complications. The 
case material came from two sources: first, 
all cases coded under “fissures”, “hemor­
rhoids”, “anorectal abscesses” and “fistu­
las”, and, second, charts of patients with 
leukemia, lymphoma and myeloma contain­
ing evidence of anorectal problems. These 
two sources yielded 10 and 7 patients, re­
spectively. Of these 17 patients, 14 were 
men and 3 were women; their ages ranged 
from 18 to 71 years.
The anorectal symptoms, pathologic de­
tails, hematologic status (i.e., peripheral 
blood count, relapse or remission), drugs 
administered, results of bacteriologic studies, 
operative procedures and clinical course of 
the patients were noted.
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TABLE I.—Clinical Details of 17 Patients with H ematologic M alignant Neoplasms and
Associated Anorectal Lesions
Patient
no.
Age
(yr) Sex Diagnosis
Peripheral blood values 
Hb Leukocyte Platelet
(g/dl) [ x i o v i )  (x io ° / D Clinical status Course
Hemorrhoids
i 55 M CML* 9.5 175 28 No remission Had hemorrhoidectomy;
died of intracranial
bleeding
2 45 M Myeloma 9.0 3.7 138 Remission Alive
3 71 M Myeloma 10.0 6.3 54 No remission Died of metastasis
4 58 M Hodgkins’ 16.0 8.8 300 Remission Alive
5 39 M CML 10.7 260 258 Remission Alive
Anorectal ulcers
6 32 M AML) 12.2 88 10 No remission Died of sepsis
7 32 M AMML{ 9.0 2.8 134 Partial remission Died of infarcted colon
8 61 M AMML 11.0 6.2 11 Relapse Died of sepsis
9 35 M AML 11.2 3.7 89 Remission Died of appendicitis
10 19 F AMML 7.5 23.6 11 Induction Alive — remission
11 64 M AML 8.0 11.5 640 Relapse Had I & D; died of sepsis
12 33 F AML 8.3 211 132 Relapse Died of sepsis
13 25 M ALL§ 5.9 0.3 10 Relapse Died of sepsis
Anal and perineal necrosis
14 24 M Lymphoma 8.0 0.5 67 No remission Had I & D 2x; alive
15 39 M AML 8.4 0.4 10 Relapse Died of sepsis
Perirectal abscess
16 18 M AML 10.5 4.8 25 No remission Had I & D; died of septic
shock
17 47 M AML 8.0 0.8 10 Induction — Had I & D; survived
remission septic shock
*Chronic myelogenous leukemia.
(Acute myelocytic leukemia.
{Acute myelomonocytic leukemia.
§Acute lymphoblastic leukemia.
R esu l t s
The clinical details of the 17 patients are 
summarized in Table I. The diagnosis was 
leukemia in 13 patients, lymphoma in 2 
and multiple myeloma in 2.
The Anorectal Lesion
Pathologic type.—There were essentially 
four types of anorectal lesion:
1. Prolapsed and thrombosed hemor­
rhoids (five patients). These lesions pro­
duce local symptoms only—pain, tender­
ness and bleeding— and never fever or sys­
temic toxicity. Except for patient 1, in whom 
hemorrhoidectomy was performed for per­
sistent disabling symptoms, all responded to 
conservative treatment.
2. Discrete ulcers in the anorectum 
(eight patients). This was the commonest le­
sion. Single or multiple shallow ulcers were 
seen in the anal canal and perianal region, 
with surrounding cellulitis but no true sup­
puration. Tissue taken from seven patients
was examined. Biopsies of the ulcers in 
three patients showed no evidence of leu­
kemic infiltration. In an additional four 
patients tissue was examined at autopsy; 
none of the lesions contained any pus but 
one manifested leukemic infiltration. All but 
one of the patients had fever and systemic 
toxicity, and three had positive blood cul­
tures. One patient inadvisedly underwent 
incision and drainage twice, necrotizing 
proctitis subsequently developing with 
sloughing of perianal skin.
3. Necrosis of the anus and perianal area 
(two patients). The entire anorectum and 
perianal region is black, necrotic and ready 
to slough. Both patients complained of 
severe local pain and tenderness and sys­
temic toxicity. In one of these patients ne­
crosis followed incision and drainage.
4. True perirectal abscess (two patients). 
In both patients incision yielded definite 
pus and in both the systemic signs subsided 
after drainage. In one, however, the abscess 
recurred secondary to an infected hema-
November 1975 THE CANADIAN JOURNAL OF SURGERY 
TABLE II.—Summary of Bacteriologic F indings
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Organism cultured
Culture site
Patient Leukocyte 
(x 109/ l)
Temperature
(°C)no. Anorectum Blood
6 88 38 Not done E. coli
7 2.8 39 E. coli; Pseudomonas sp.; Str. 
fecalis; Diptheroids; Candida sp.
No growth
9 3.7 37 Hemolytic strept.; Str. fecalis; Bacteroides 
sp.
E. coli; Sir. viridans; S. aureus; C. per- 
fringens; Peptosirept. sp.; Bacteroides sp.
No growth
10 23.6 39 Fusobacterium sp.
11 11.5 39 Not done E. coli13 0.3 40 Not done E. coli14 0.5 39 Hemolytic strept.; Sir. fecalis; E. coli; 
Bacteroides sp.; Eubacterium sp.
No growth
15 0.4 39 P aeruginosa; E. coli; Sir. fecalis; 
Diptheroids; Klebsiella sp.
P. aeruginosa
16 4.8 40 Not done S. aureus17 0.8 40 E. coli; Bacteroides sp.; Klebsiella sp.; 
Candida sp.
Klebsiella sp.
toma; in the other, septicemia was treated 
successfully and a successful remission of 
his leukemia followed chemotherapy.
Predisposing factors.—Two patients had 
a history of anorectal complaints; four had 
had episodes of diarrhea at some time prior 
to the development of the anorectal lesion; 
and three noted severe constipation, with 
repeated manual fecal disimpaction. Thus, 
over half of the patients had either pre­
existing anorectal problems or disordered 
bowel pattern. The anorectal problem was 
the presenting symptom of one patient (pa­
tient 1) with leukemia.
Management.—Most of the patients were 
treated conservatively (i.e., with sitz baths, 
bulk laxative and stool softeners, and pe­
rineal heat lamp) while full attention was 
directed to achieving remission. In febrile 
patients, cultures of anorectum and blood 
were taken (in addition to the other usual 
cultures) and broad-spectrum antibiotics 
were administered. Five patients were just 
examined under anesthesia; three underwent 
biopsies of the anorectum; one had hemor­
rhoidectomy while in remission—he had 
platelet transfusion in the perioperative pe­
riod; and four were treated by incision and 
drainage, pus being obtained in two.
Associated mortality.—The overall mor­
tality rate was 53%; for patients who were 
not in remission the rate was 69%, com­
pared with zero mortality for those in re­
mission. All but one of the deaths were di­
rectly attributable to septicemia secondary 
to the anorectal complication.
Microbiology.—With respect to blood 
culture, among 11 patients with fever, blood 
culture was positive in 7 (Table II). Two of 
these seven survived— patient 17, with 
Klebsiella septicemia and patient 10, with 
Fusobacterium.
Culture of the anorectum showed that 
the commonest organisms were Escherichia 
coli and Streptococcus fecalis, followed by 
Bacteroides sp. and hemolytic streptococci.
Hematologic status.— The peripheral leu­
kocyte counts (x 10V0 ranged from 0.3 to 
260, the count did not appear to cor­
relate with the prognosis. The single most 
important correlate of the prognosis and 
clinical course as regards anorectal com­
plications was whether the primary disease 
was in relapse or remission.
D iscussion
The management of the patient with an­
orectal complications that produce local 
symptoms only is conservative. Bowel func­
tion is maintained as near as possible to 
normal, good perineal hygiene is practised, 
and the need for effort is directed to control 
of the primary disease. Controversy arises, 
however, either when the primary disease 
is not in remission, or when the anorectal 
lesion leads to clinical septicemia. The role 
of surgery in these instances has not been
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clearly defined. As such patients are critic­
ally ill, injudicious surgical intervention may 
not only be ineffective but may also make 
the local lesion worse and add to the already 
high mortality.1'4 On the other hand, it has 
been argued that, because of the severely 
compromised host defence mechanism in 
these patients,5 any infective focus should 
be aggressively removed or drained.6- 7 
Part of this controversy arises from the 
frequent misuse of the word “abscess”. One 
experience shows that only in the minority 
of lesions is there actual suppuration that 
can be drained surgically. Most of the le­
sions are ulcerative and nonsuppurative. We 
believe that most of the so-called atypical 
abscesses1- 3 that have been described refer 
to this type of lesion. In these instances, 
surgical drainage is clearly not only impos­
sible but also hazardous. Blank,3 for exam­
ple, reported that in two patients the whole 
anorectum became necrotic and sloughed 
following injudicious incision and drain­
age. Our experience is similar; in one of 
our patients incision and drainage was per­
formed twice, the second procedure being 
done in the belief that the first was “in­
adequate”, despite the fact that no pus was 
obtained on both occasions. But when there 
is frank suppuration, with an evident col­
lection of pus, surgical drainage should be 
undertaken even if the disease is not in re­
mission; and this requires intensive sup­
portive therapy with transfusion of blood 
and platelets in the perioperative period.
Evidently tissue inflammation in the 
anorectal or perianal region manifests itself 
differently in the patient who does not have 
leukemia or a similar condition from the 
patient who does. In the former type of pa­
tient, suppuration cannot be detected easily 
until it is in an advanced stage, and it may 
even be undetectable, especially with the 
high intermuscular type of lesion.8 None 
the less, when such a patient is examined 
under anesthesia, the internal opening may 
become obvious or a sensation of “bog­
giness” felt. In the leukemic patient, how­
ever, this is rarely the case; instead there 
may be sloughing and ulcerative lesions, 
and, at autopsy, no collection of pus is 
found.
A form of treatment of which we have
had no experience is irradiation of the 
anorectum.1 A dose of 300 to 400 rads is 
delivered to the anorectum over 1 to 3 days; 
this apparently facilitates resolution of the 
induration or conversion to frank suppura­
tion, which can be drained.
The pathogenesis of the anorectal lesion 
in patients with hematologic malignancies is 
not clear. The lesions may be an area of 
neoplastic infiltration similar to such de­
veloping in other mucosal surfaces (e.g., 
gums), in, for example, monocytic leuke­
mia.9 However, histologic proof of infiltra­
tion is uncommon (Fig. I);3’ 4 in the present 
series this was noted in only one of the seven 
examined. Nor does this hypothesis explain 
the involvement of the anorectum in the aleu­
kemic forms of leukemia or the similar 
pathologic features noted in lesions occur­
ring in patients with non-neoplastic agranu­
locytosis.10 Givler,11 on the basis of his 
studies on the gross and histologic features 
of the anorectum in these cases and the high 
incidence of Pseudomonas organisms cul­
tured, has suggested that the abnormality in 
the rectum is caused specifically by the 
Pseudomonas toxins— particularly the pro­
tease and lecithinase components. Although 
Pseudomonas sp. are the commonest among 
the organisms to be recovered in most of the 
series,2’ 11 this is not universally true,4 and 
this has not been our experience.
Fig. 1.—Section from biopsy of ulcer in anal 
canal in patient with acute leukemia (patient 1). 
Note abundant chronic inflammatory cells (lym­
phocytes and plasma cells) but absence of true 
leukemic infiltration (hematoxylin and eosin, re­
duced by 26% from x 250).
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The most likely pathogenesis is that sug­
gested by Schimpff, Wiernik and Block,2 
who postulated a traumatic origin. An epi­
sode of disordered bowel function (e.g., 
diarrhea or constipation), or trauma to the 
anorectum, may produce small mucosal tears 
in the anal canal that may facilitate bacterial 
invasion. This, in the absence of normally 
functioning leukocytes and other host de­
fence mechanism commonly associated with 
hematologic malignancies,5 is enough to 
trigger a fulminating and spreading infective 
process. Like others,2 we have been im­
pressed with the number of patients in whom 
a history of disordered bowel movement 
antedates the anorectal complaints. Further­
more, fatal anorectal complications have fol­
lowed trauma induced by barium enema 
examinations in such patients.3
We had the opportunity to study granu­
locyte function in one of our patients with 
acute leukemia; interestingly, except for an 
abnormal phagocytosis, there was no 
evidence of abnormality in intracellular kill­
ing, chemotaxis or hydrogen peroxide-mye­
loperoxidase activation. Abnormalities in 
these functions have been described in 
acute leukemia.12
R ecommendations
Anorectal and perianal complications de­
veloping in patients with hematologic 
malignant neoplasms are highly lethal. We 
recommend the following plan of manage­
ment:
1. Patients presenting initially for chemo­
therapy are interviewed specifically with 
reference to any previous history of ano­
rectal problems and the anorectal area is 
carefully examined.
2. Patients at high risk of developing this 
complication should be treated with an ac­
tive prophylactic regimen: sitz baths, bulk 
laxatives, maintenance of normal bowel 
function and practice of good perineal 
hygiene.
3. The anorectal area must be suspected 
as the focus in any febrile patient with 
hematologic malignant neoplasms. The area 
must be examined carefully, under anesthe­
sia if necessary, and cultures taken.
4. When the anorectal area is thought to 
harbour the cause of fever, broad-spectrum 
antibiotics to cover the common organisms 
cultured (coliforms, bacteroids, Pseudo­
monas) must be prescribed after appropriate 
cultures are taken.
5. Surgical drainage is indicated only 
when actual suppuration can be demon­
strated (either on examination or aspiration).
6. Other elective procedures (e.g., hemor­
rhoidectomy) must be performed only if the 
patient’s primary condition is in remission 
and the anorectal lesion is causing per­
sistent disabling symptoms.
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TENSION PNEUMOPERITONEUM: CASE REPORT AND REVIEW 
OF THE LITERATURE*
VINCENT ECHAVE, M D, MAXIMO FLORES, MD and W. LINDSAY OGILVY, MB, ChB, FRCS[C], FACS
Summary: Tension pneumoperitoneum in an 81- 
year-old man resulted from the perforation of 
an ulcer on the posterior aspect of the first 
stage of the duodenum into the lesser sac. This 
condition, though rare, should be considered in 
the differential diagnosis of the massively dis­
tended abdomen. A number of different causes 
of this condition have been reported, most of 
which are associated with various diagnostic 
and therapeutic procedures. Treatment is early 
laparotomy.
Resume: Un cas de pneumoperitoine tensionnel 
chez un homme de 81 ans, provenait de la per­
foration d’un ulcere situe sur la face posterieure 
de la premiere portion du duodenum dans I’ar- 
riere cavite. Dans la diagnostic differentiel d'un 
abdomen fortement distendu, il serait sage d'en- 
visager la possibility de cette pathologie qui 
existe, bien qu’elle soit rare. Le pneumoperitoi­
ne peut avoir des causes tres differentes, dont 
la majority relevent de diverses manoeuvres 
instrumentales, soit diagnostiques, soit thera- 
peutiques. Le traitement consiste a pratiquer 
rapidement une laparotomie.
The patient appeared to be moderately dis­tressed. His blood pressure was 120/80 mm Hg, his pulse was 95 beats/min and regular and his rectal temperature was 38°C. The abdomen was grossly distended, diffusely tender and tympanitic; bowel sounds were heard but were distant. Rectal examination 
revealed no tenderness in the pelvis, and the rectal ampulla was empty. Sigmoidoscopy was 
normal to 20 cm. The initial clinical impres­sion was that of large bowel obstruction.
The total leukocyte count was 9.5 x 109//  
and the hemoglobin concentration was 12.5 g/ dl; electrolyte values and results of urinalysis were normal. A chest radiograph (Fig. 1) 
revealed chronic changes in both lung fields 
with elevation of both hemidiaphragms, but no free air was manifest under the diaphragm. 
Abdominal radiographs (Figs. 2 and 3) were initially interpreted as visualizing massive 
colonic distension secondary to low obstruc­tion. To locate the site of obstruction, barium was introduced into the colon, but it flowed freely as far as the cecum and revealed no 
site of obstruction (Fig. 4). Subsequently, the
T e n s io n  pneumoperitoneum is a rare con­
dition that is characterized by the presence 
of free air under tension within the peri­
toneal cavity. It was apparently first de­
scribed by Brunzel and Oberst in 1917,1 
and only a few cases have been described 
since. This paper is a report of a further 
case, together with a review of the literature.
C a se  R e po r t
An 81-year-old man was admitted to hos­pital with a 4-day history of diffuse abdominal 
discomfort and progressive abdominal disten­
sion. There was no associated nausea, vomit­ing, fever or chills. He had had a normal 
bowel movement 2 days before admission. One year previously he had undergone a sig­moid resection for volvulus of the sigmoid colon.
*From the Department of surgery, The Montreal General Hospital and McGill University, Mont­real, Que.
Reprint requests to: Dr. W. L. Ogilvy, Depart­ment of surgery, The Montreal General Hospital, 1650 Cedar Ave., Montreal, PQ H3G 1A4. Fig- 1.—Absence of free air under diaphragm (chest upright).
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Fig. 2.—Apparent distended loops of bowel 
(abdomen upright); appearance later recognized 
to be that of huge pneumoperitoneum.
initial abdominal radiographs were considered 
to show a huge pneumoperitoneum.
At laparotomy, the gross distension disap­
peared as soon as the peritoneum was opened. 
Exploration revealed an ulcer on the posterior 
aspect of the first stage of the duodenum 
(Fig. 5) that had perforated into the lesser sac 
and had obviously been functioning as a one­
way valve. Soiling of the peritoneal cavity was 
minimal. A  subtotal gastrectomy was per­
formed.
Fig. 4. —Absence of evidence of distension or 
obstruction of colon.
Postoperative recovery was relatively un­
eventful and he was discharged from hospital 
on the 14th postoperative day. When seen at 
follow-up he was doing well.
D iscussion
With pneumoperitoneum as the present­
ing sign of a perforated viscus there is usual­
ly just enough free air to allow the diagnosis 
to be made; air is seen under the diaphragm 
in the upright chest2 or abdominal radio­
graph. Normally the perforation becomes 
sealed by the omentum or surrounding 
viscera. Larger amounts of free air than 
usual are associated with free perforation
Fig. 3.—Apparent massive colonic distension, but appearance in fact of huge pneumoperitoneum.
November 1975 THE CANADIAN JOURNAL OP SURGERY 587
Fig. 5.—Perforated ulcer on posterior aspect of 
first stage of duodenum.
of the colon more often than with perfora­
tion of the upper gastrointestinal tract.
In the patient whose case we have de­
scribed, the perforation was located on the 
posterior aspect of the first stage of the 
duodenum. An ulcer in this location tends 
to cause penetration with or without 
hemorrhage and the occurrence of free per­
foration is in itself unusual. Since the pa­
tient presented with a 4-day history of in­
creasing abdominal distension, the perfora­
tion must have been acting as a one-way 
valve mechanically similar to that with a 
tension pneumothorax.
Also of interest was the minimal con­
tamination of the peritoneal cavity by 
gastric contents, in spite of the delay be­
tween the onset of symptoms and the lapa­
rotomy. As Singer has pointed out, a true 
tension pneumoperitoneum results only 
when a large volume of air escapes alone 
and there is little or no extravasation of 
liquid material to cause a peritonitis.3
Tension pneumoperitoneum should be 
considered in the differential diagnosis of 
the massively distended abdomen, but it is 
essentially a radiologic diagnosis. Irrespec­
tive of the cause the treatment should be 
early laparotomy;4 delay in treatment will 
only aggravate the abdominal condition and 
produce further cardiorespiratory embarrass­
ment.
TABLE I.—Causes of Tension Pneumoperi­
toneum
Rupture of hollow viscus with one-way valve-like 
mechanism
Perforation or rupture of cyst in pneumatosis cys- 
toides intestinalis
Secondary to pneumothorax through pleuroperi­
toneal communication 
Congenital (newborn)
Acquired
Trauma
Post-thoracotomy
Peritonitis resulting from injection with gas- 
producing organism
Therapeutic procedures 
For pulmonary tuberculosis 
Preoperative preparation for repair of large ab­
dominal hernias 
Preparation for laparoscopy
Obstetric manipulations
The causes of tension pneumoperitoneum 
are classified in Table I. Air is introduced 
under tension into the peritoneal cavity for 
various diagnostic and therapeutic reasons. 
Free air in the peritoneal cavity after lapa­
rotomy is usually absorbed within a week, 
although larger volumes of air may persist 
for longer3’ 0 and a few cases have been re­
ported in which tension pneumoperitoneum 
followed laparotomy.7 The majority of re­
ported cases of tension pneumoperitoneum 
have been related to anastomotic leak, per­
forated viscus, infection of the abdominal 
cavity with gas-forming organisms, and 
other less common conditions;1- 2’ 8-111 
other causes have also been reported.11-20
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CRITIQUE OF ITEM 404 (SESAP II)
Coronary artery bypass grafting is a new procedure which has not been completely 
evaluated. The long-term results of grafting procedures utilizing the autogenous veins 
or the internal mammary artery for bypassing the occluded portions of the proximal 
coronary artery are continually being reevaluated. There is agreement that the risk of 
the operative procedure is related to the extensiveness of the arterial changes and the 
impairment of ventricular function which may be due to factors other than ischemia. 
Evaluation of ventricular function is a consideration in the choice of patients. Those 
with severe dysfunction are found to have poor tolerance for the operation; higher 
mortality is incurred in this group of patients.
The indications for coronary artery revascularization are slightly enlarged in the 
case of patients on whom the open-heart procedure is done for other lesions, such as 
valvular heart disease or ventricular aneurysm, as in answer (3). Certain lesions, 
because of their location, such as the main left coronary artery, are more 
life-threatening than similar degrees of stenosis in more peripheral vessels. The 
indication for operation in this group seems more urgent, as represented in answer 
(2). The evaluation of angina pectoris remains somewhat less well defined since 
patients with progressive angina with impending coronary occlusion would be a 
logical group for whom the operation should be considered. Selection within this 
group requires somewhat greater skill and more sophisticated methods for 
evaluating the condition of these patients. Those with disabling angina are given 
some priority if arteriographic studies show that their situation is favorable for grafting.
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B O O K  R E V I E W S
CLINICAL THYROIDOLOGY. Joel I. Ham­
burger. 206 pp. Illust. Joel I. Hamburger, 
Northland Thyroid Laboratory, PC, 20905 
Greenfield, Ste 3000, Southfield, MI, 47075, 
USA, 1974. $9.75. Paperbound.
This fascinating and eminently readable addi­
tion to the thyroid literature describes how the 
author deals with the diagnosis and treatment 
of thyroid problems that are most frequently 
encountered in daily office practice. After 
briefly reviewing the pathophysiology, the 
author deals witn the diagnosis and treatment 
of hyperthyroidism, hypothyroidism, simple 
goitre, the thyroid nodule (thyroid cancer) and 
painful thyroid disorders.
The book is consistently good; highlights are 
the presentation of thyroid function tests, their 
selection and interpretation. However, I found 
no mention of the perchlorate discharge test 
and of the usefulness, if any, of antithyroid 
antibody determinations.
Numerous figures, tables, illustrations and 
flow charts of high quality are used to sum­
marize the main points made in each chapter 
and are excellent for use in lecturing on 
various aspects of thyroid disorders.
Modern-day concepts regarding the surgical 
aspects of thyroid disease, particularly the 
place of surgery in the management of hyper­
thyroidism and the thyroid nodule, are well 
presented in considerable detail. While the 
number of cases of hyperthyroidism being 
managed by thyroidectomy is decreasing, it is 
still important that physicians and surgeons 
be aware of the methods available to provide 
proper control of the hyperthyroid state be­
fore operation. The usefulness of propranolol 
in this situation is highlighted, as well as its 
use in patients with thyroid storm.
The concluding chapter on obesity and its 
relationship to thyroid function could well 
have ended after the excellent statistical pre­
sentation of data on change in weight after suc­
cessful treatment of hypothyroidism. Instead, 
the author continues with observations on the 
personality of the obese patient and the man­
agement of obesity, which are inappropriate in 
this otherwise excellent text.
I thoroughly enjoyed this book and strongly 
recommend it for all levels of study of thyroid 
disorders.
C. Reynolds
St. Paul’s Hospital,
Vancouver, BC.
DIGESTIVE SURGERY. Proceedings of the 
2nd World Congress of “Collegium Inter­
nationale Chirurgiae Digestivae” Strasbourg, 
June 9-10-11, 1972. Edited by L. F. Hol- 
lender and G. D’Onofrio. 969 pp. IUust. 
Piccin Medical Books, Padua, 1974. $60.00.
Like the published proceedings of the first 
world congress on digestive surgery, this ed­
ition presents manuscripts of papers given 
at an international meeting; this one was held 
in June 1972. The book is organized in sec­
tions devoted to papers relating to the eso­
phagus, stomach and duodenum, small intes­
tine and colon. The esophageal section, for 
example, has discussions on the use of mano­
metry, a new method for ligation of esopha­
geal varices to control bleeding, a review of 
esophageal diverticulae and another method 
for hiatal hernia repair. There are some unu­
sual case presentations, such as those relating 
to Crohn’s disease of the esophagus and acid 
burns of the stomach. Since the authors are 
international authorities from many different 
countries, some of the ideas presented differ 
a little from those underlying standard North 
American practice.
The format of this book is attractive. The 
paper and printing are excellent. There are 
many illustrations and much information is 
presented in tables so that the text is easily 
read. A few of the presentations are in French.
This is not a textbook of surgery and it is 
not designed for undergraduate study. It would 
be useful for academic surgeons interested in 
the gastrointestinal tract.
S. E. Carroll
Department of surgery,
St. Joseph’s Hospital,
London, ON.
HOFFMANN’S DOUBLE FRAME EXTER­
NAL ANCHORAGE. Methods, Applica­
tions and Results in 160 Observations. 
Henry Connes. Translated by W. A. Birn- 
baum. 117 pp. Illust. Editions GEAD, Paris, 
1973. F90,00. $2.20 (approx.). Paperbound.
Very little has been written in English about 
external skeletal fixation in the past 20 years. 
The English translation of this small book by 
the chief orthopedic resident at Montpellier 
Hospital in France helps fill this gap. Histor­
ical considerations are considered as well as 
a large bibliography, mainly French (281 ref-
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erences). Unfortunately neither the American contributions of Haynes, Stader and Anderson, nor the Canadian contribution of Naden in over 1000 cases are mentioned.In this book Connes gives a good review of Hoffmann’s method of external skeletal fixation as used in 160 cases. Generally, three parallel pins are used at each fixation site completely through the limb, if possible in the coronal plane so that double external frames can be utilized; if this is not possible, pins may be placed in the sagittal plane. This differs from the angled-pin insertion of Ander­son, though double-frame external anchorage 
is also used in the Anderson apparatus when possible. The double-frame mounting of Hoff­mann is rigid and allows compression neutral­ization or distraction.Indications are strictly limited. It is useful in severe, open fractures with soft-tissue loss, infected nonunions, arthrodesis of the knee and shoulder, open fracture dislocations, pelvic fractures with major symphysial disruption and cross-leg skin flaps. Other uses are also dis­cussed. The placement of about 1000 nails has been done in 160 cases. Pin-track sepsis was not a great problem.This short paperback will be of help to those who manage severe fractures not amen­able to internal fixation or simpler nonoper­ative methods, and helps update our knowl­edge of external skeletal fixation in the European medical literature.
L. H. Bartlett
Department of orthopedics,Lions’ Gate Hospital,North Vancouver, BC.
SURGERY OF THE LIVER, PANCREAS 
AND BILIARY TRACT, Edited by John 
S. Najarian and John P. Delaney. 658 pp. 
Illust. Stratton Intercontinental Medical Book Corporation, New York; Longman 
Canada Limited, Toronto, 1975. $28.00.
This book contains selected papers from a 
postgraduate course held at the University of
Minnesota in 1974. The text is divided into five sections —• on the spleen, the biliary tract, the pancreas, the liver and portal hyper­tension. Concepts new and old are dealt with authoritatively both in the presented papers and in an extensive open discussion.The book provides answers to common problems that will interest practising surgeons and housemen alike. The following are some examples. Must a common duct stone smaller than 3 mm be removed? — No, it will pass if the common bile duct is dilated to at least 1.4 cm. What is the procedure of choice for the patient with multiple stones in the com­mon bile duct? — The consensus is chole- dochoduodenostomy without stent. Should one consider peritoneal dialysis in patients with pancreatitis? — Yes, in the malignant form 
of acute pancreatitis, especially when there is a change in the sensorium of the patient. Should one internally drain “pseudocysts” of the pancreas early following acute pancrea­titis? — The consensus is that one should not, 
because at this stage the pseudocyst consists of edematous pancreas or a rupture with col­lection of pancreatic secretions without a fi­brous wall; one should wait for 3 or 4 months and perform internal drainage only in symp­tomatic patients.
Although this text concentrates on patient management, pathogenesis of disease and diag­nosis are presented in an interesting manner. The sections on the investigation of patients with liver disease are particularly concise. The 
case for identification of hepatotrophic factors in splanchnic venous drainage is presented elegantly, together with suggestions for clinical application.
This text covers five subjects of great cur­rent interest, particularly to surgeons. It will be useful not only to those in training but 
also, because of the postgraduate level of presentation and discussion, to practising sur­geons as well.
L. D. MacLean
Department of surgery,Royal Victoria Hospital,Montreal, PQ.
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